NVIDIA CORP, 10-K filed on 3/18/2022
Annual Report
v3.22.0.1
Cover Page - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Jan. 30, 2022
Mar. 11, 2022
Jul. 30, 2021
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Jan. 30, 2022    
Current Fiscal Year End Date --01-30    
Document Transition Report false    
Entity File Number 0-23985    
Entity Registrant Name NVIDIA CORP    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 94-3177549    
Entity Address, Address Line One 2788 San Tomas Expressway    
Entity Address, City or Town Santa Clara    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 95051    
City Area Code 408    
Local Phone Number 486-2000    
Title of 12(b) Security Common Stock, $0.001 par value per share    
Trading Symbol NVDA    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 467,250
Entity Common Stock, Shares Outstanding   2,510  
Documents Incorporated by Reference Portions of the registrant's Proxy Statement for its 2022 Annual Meeting of Shareholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K are incorporated by reference into Part III, Items 10-14 of this Annual Report on Form 10-K.    
Entity Central Index Key 0001045810    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Amendment Flag false    
v3.22.0.1
Audit Information
12 Months Ended
Jan. 30, 2022
Audit Information [Abstract]  
Auditor Firm ID 238
Auditor Name PricewaterhouseCoopers LLP
Auditor Location San Jose, California
v3.22.0.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Income Statement [Abstract]      
Revenue $ 26,914 $ 16,675 $ 10,918
Cost of revenue 9,439 6,279 4,150
Gross profit 17,475 10,396 6,768
Operating expenses      
Research and development 5,268 3,924 2,829
Sales, general and administrative 2,166 1,940 1,093
Total operating expenses 7,434 5,864 3,922
Income from operations 10,041 4,532 2,846
Interest income 29 57 178
Interest expense (236) (184) (52)
Other, net 107 4 (2)
Other income (expense), net (100) (123) 124
Income before income tax 9,941 4,409 2,970
Income tax expense 189 77 174
Net income $ 9,752 $ 4,332 $ 2,796
Net income per share:      
Basic (in USD per share) $ 3.91 $ 1.76 $ 1.15
Diluted (in USD per share) $ 3.85 $ 1.73 $ 1.13
Weighted average shares used in per share computation:      
Basic (in shares) 2,496 2,467 2,439
Diluted (in shares) 2,535 2,510 2,472
v3.22.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Statement of Comprehensive Income [Abstract]      
Net income $ 9,752 $ 4,332 $ 2,796
Available-for-sale debt securities:      
Net unrealized gain (loss) (16) 2 8
Reclassification adjustments for net realized gain (loss) included in net income 0 (2) 0
Net change in unrealized gain (loss) (16) 0 8
Cash flow hedges:      
Net unrealized gain (loss) (43) 9 10
Reclassification adjustments for net realized gain (loss) included in net income 29 9 (5)
Net change in unrealized gain (loss) (14) 18 5
Other comprehensive income (loss), net of tax (30) 18 13
Total comprehensive income $ 9,722 $ 4,350 $ 2,809
v3.22.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jan. 30, 2022
Jan. 31, 2021
Current assets:    
Cash and cash equivalents $ 1,990 $ 847
Marketable securities 19,218 10,714
Accounts receivable, net 4,650 2,429
Inventories 2,605 1,826
Prepaid expenses and other current assets 366 239
Total current assets 28,829 16,055
Property and equipment, net 2,778 2,149
Operating lease assets 829 707
Goodwill 4,349 4,193
Intangible assets, net 2,339 2,737
Deferred income tax assets 1,222 806
Other assets 3,841 2,144
Total assets 44,187 28,791
Current liabilities:    
Accounts payable 1,783 1,149
Accrued and other current liabilities 2,552 1,777
Short-term debt 0 999
Total current liabilities 4,335 3,925
Long-term debt 10,946 5,964
Long-term operating lease liabilities 741 634
Other long-term liabilities 1,553 1,375
Total liabilities 17,575 11,898
Commitments and contingencies - see Note 13
Shareholders’ equity:    
Preferred stock, $0.001 par value; 2 shares authorized; none issued 0 0
Common stock, $0.001 par value; 4,000 shares authorized; 2,506 shares issued and outstanding as of January 30, 2022; 3,859 shares issued and 2,479 outstanding as of January 31, 2021 3 3
Additional paid-in capital 10,385 8,719
Treasury stock, at cost (None as of January 30, 2022 and 1,380 shares as of January 31, 2021) 0 (10,756)
Accumulated other comprehensive income (loss) (11) 19
Retained earnings 16,235 18,908
Total shareholders' equity 26,612 16,893
Total liabilities and shareholders' equity $ 44,187 $ 28,791
v3.22.0.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Jan. 30, 2022
Jan. 31, 2021
Statement of Financial Position [Abstract]    
Preferred stock, par value (in USD per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 2,000,000 2,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (in USD per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 4,000,000,000 4,000,000,000
Common stock, shares issued (in shares) 2,506,000,000 3,859,000,000
Common stock, shares outstanding (in shares) 2,506,000,000 2,479,000,000
Treasury stock (in shares) 0 1,380,000,000
v3.22.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock Outstanding
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance, common stock outstanding (in shares) at Jan. 27, 2019   2,423,000,000        
Beginning balances, shareholders' equity at Jan. 27, 2019 $ 9,342 $ 3 $ 6,049 $ (9,263) $ (12) $ 12,565
Increase (Decrease) in Shareholders' Equity            
Net income 2,796         2,796
Other comprehensive income (loss), net of tax 13       13  
Issuance of common stock from stock plans (in shares)   39,000,000        
Issuance of common stock from stock plans  149   149      
Tax withholding related to vesting of restricted stock units (in shares)   (12,000,000)        
Tax withholding related to vesting of restricted stock units (551)     (551)    
Cash dividends declared and paid (390)         (390)
Stock-based compensation 845   845      
Ending balance, common stock outstanding (in shares) at Jan. 26, 2020   2,450,000,000        
Ending balances, shareholders' equity at Jan. 26, 2020 12,204 $ 3 7,043 (9,814) 1 14,971
Increase (Decrease) in Shareholders' Equity            
Net income 4,332         4,332
Other comprehensive income (loss), net of tax 18       18  
Issuance of common stock from stock plans (in shares)   40,000,000        
Issuance of common stock from stock plans  194   194      
Tax withholding related to vesting of restricted stock units (in shares)   (11,000,000)        
Tax withholding related to vesting of restricted stock units (942)     (942)    
Cash dividends declared and paid (395)         (395)
Fair value of partially vested equity awards assumed in connection with acquisitions 86   86      
Stock-based compensation $ 1,396   1,396      
Ending balance, common stock outstanding (in shares) at Jan. 31, 2021 2,479,000,000 2,479,000,000        
Ending balances, shareholders' equity at Jan. 31, 2021 $ 16,893 $ 3 8,719 (10,756) 19 18,908
Increase (Decrease) in Shareholders' Equity            
Net income 9,752         9,752
Other comprehensive income (loss), net of tax (30)       (30)  
Issuance of common stock from stock plans (in shares)   35,000,000        
Issuance of common stock from stock plans  281   281      
Tax withholding related to vesting of restricted stock units (in shares)   (8,000,000)        
Tax withholding related to vesting of restricted stock units (1,904)   (614) (1,290)    
Cash dividends declared and paid (399)         (399)
Fair value of partially vested equity awards assumed in connection with acquisitions 18   18      
Stock-based compensation 2,001   2,001      
Retirement of Treasury Stock $ 0   (20) 12,046   (12,026)
Ending balance, common stock outstanding (in shares) at Jan. 30, 2022 2,506,000,000 2,506,000,000        
Ending balances, shareholders' equity at Jan. 30, 2022 $ 26,612 $ 3 $ 10,385 $ 0 $ (11) $ 16,235
v3.22.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) - $ / shares
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Statement of Stockholders' Equity [Abstract]      
Cash dividends declared and paid (USD per common share) $ 0.16 $ 0.16 $ 0.16
v3.22.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Cash flows from operating activities:      
Net income $ 9,752 $ 4,332 $ 2,796
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation expense 2,004 1,397 844
Depreciation and amortization 1,174 1,098 381
Deferred income taxes (406) (282) 18
(Gains) losses on investments in non-affiliates, net (100) 0 1
Other 47 (20) 4
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable (2,215) (550) (233)
Inventories (774) (524) 597
Prepaid expenses and other assets (1,715) (394) 77
Accounts payable 568 312 194
Accrued and other current liabilities 581 290 54
Other long-term liabilities 192 163 28
Net cash provided by operating activities 9,108 5,822 4,761
Cash flows from investing activities:      
Proceeds from maturities of marketable securities 15,197 8,792 4,744
Proceeds from sales of marketable securities 1,023 527 3,365
Purchases of marketable securities (24,787) (19,308) (1,461)
Purchases related to property and equipment and intangible assets (976) (1,128) (489)
Acquisitions, net of cash acquired (263) (8,524) (4)
Investments and other, net (24) (34) (10)
Net cash provided by (used in) investing activities (9,830) (19,675) 6,145
Cash flows from financing activities:      
Issuance of debt, net of issuance costs 4,977 4,968 0
Proceeds related to employee stock plans 281 194 149
Payments related to tax on restricted stock units (1,904) (942) (551)
Repayment of debt (1,000) 0 0
Dividends paid (399) (395) (390)
Principal payments on property and equipment (83) (17) 0
Other (7) (4) 0
Net cash provided by (used in) financing activities 1,865 3,804 (792)
Change in cash and cash equivalents 1,143 (10,049) 10,114
Cash and cash equivalents at beginning of period 847 10,896 782
Cash and cash equivalents at end of period 1,990 847 10,896
Supplemental disclosures of cash flow information:      
Cash paid for income taxes, net 396 249 176
Cash paid for interest $ 246 $ 138 $ 54
v3.22.0.1
Organization and Summary of Significant Accounting Policies
12 Months Ended
Jan. 30, 2022
Accounting Policies [Abstract]  
Organization and Summary of Significant Accounting Policies Organization and Summary of Significant Accounting Policies
Our Company
Headquartered in Santa Clara, California, NVIDIA was incorporated in California in April 1993 and reincorporated in Delaware in April 1998.
All references to “NVIDIA,” “we,” “us,” “our” or the “Company” mean NVIDIA Corporation and its subsidiaries.
On July 19, 2021, we executed a four-for-one stock split of our common stock. All share, equity award, and per share amounts and related shareholders' equity balances presented herein have been retroactively adjusted to reflect the Stock Split.
Fiscal Year
We operate on a 52- or 53-week year, ending on the last Sunday in January. Fiscal years 2022 and 2020 were both 52-week years. Fiscal year 2021 was a 53-week year.
Reclassifications
Certain prior fiscal year balances have been reclassified to conform to the current fiscal year presentation.
Principles of Consolidation
Our consolidated financial statements include the accounts of NVIDIA Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from our estimates. On an on-going basis, we evaluate our estimates, including those related to revenue recognition, cash equivalents and marketable securities, accounts receivable, inventories, income taxes, goodwill, stock-based compensation, litigation, investigation and settlement costs, restructuring and other charges, and other contingencies. The inputs into our judgments and estimates consider the economic implications of COVID-19. These estimates are based on historical facts and various other assumptions that we believe are reasonable.
Revenue Recognition
We derive our revenue from product sales, including hardware and systems, license and development arrangements, software licensing, and cloud services. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract (where revenue is allocated on a relative standalone selling price basis by maximizing the use of observable inputs to determine the standalone selling price for each performance obligation); and (5) recognition of revenue when, or as, we satisfy a performance obligation.
Product Sales Revenue
Revenue from product sales is recognized upon transfer of control of products to customers in an amount that reflects the consideration we expect to receive in exchange for those products. Certain products are sold with support or an extended warranty for the incorporated system, hardware, and/or software. Support and extended warranty revenue are recognized ratably over the service period, or as services are performed. Revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers.
For products sold with a right of return, we record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized, based primarily on historical return rates. However, if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required to properly reflect our estimated exposure for product returns.
Our customer programs involve rebates, which are designed to serve as sales incentives to resellers of our products in various target markets, and marketing development funds, or MDFs, which represent monies paid to our partners that are earmarked for market segment development and are designed to support our partners’ activities while also promoting NVIDIA products. We account for customer programs as a reduction to revenue and accrue for potential rebates and MDFs based on the amount we expect to be claimed by customers.
License and Development Arrangements
Our license and development arrangements with customers typically require significant customization of our IP components. As a result, we recognize the revenue from the license and the revenue from the development services as a single performance obligation over the period in which the development services are performed. We measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project. If a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period.
Software Licensing
Our software licenses provide our customers with a right to use the software when it is made available to the customer. Customers may purchase either perpetual licenses or subscriptions to licenses, which differ mainly in the duration over which the customer benefits from the software. Software licenses are frequently sold along with the right to receive, on a when-and-if available basis, future unspecified software updates and upgrades. Revenue from software licenses is recognized up front when the software is made available to the customer. Software support revenue is recognized ratably over the service period, or as services are performed.
Cloud Services
Cloud services, which allow customers to use hosted software over the contract period without taking possession of the software, are provided on a subscription basis or a combination of subscription plus usage. Revenue related to subscription-based cloud services is recognized ratably over the contract period. Revenue related to cloud services based on usage is recognized as usage occurs.
Product Warranties
We generally offer a limited warranty to end-users that ranges from one to three years for products in order to repair or replace products for any manufacturing defects or hardware component failures. Cost of revenue includes the estimated cost of product warranties that are calculated at the point of revenue recognition. Under limited circumstances, we may offer an extended limited warranty to customers for certain products. We also accrue for known warranty and indemnification issues if a loss is probable and can be reasonably estimated.
Stock-based Compensation
We use the closing trading price of our common stock on the date of grant, minus a dividend yield discount, as the fair value of awards of restricted stock units, or RSUs, and performance stock units that are based on our corporate financial performance targets, or PSUs. We use a Monte Carlo simulation on the date of grant to estimate the fair value of performance stock units that are based on market conditions, or market-based PSUs. The compensation expense for RSUs and market-based PSUs is recognized using a straight-line attribution method over the requisite employee service period while compensation expense for PSUs is recognized using an accelerated amortization model. We estimate the fair value of shares to be issued under our employee stock purchase plan, or ESPP, using the Black-Scholes model at the commencement of an offering period in March and September of each year. Stock-based compensation for our ESPP is expensed using an accelerated amortization model. Additionally, we estimate forfeitures at least annually based on historical experience and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates.
Litigation, Investigation and Settlement Costs
We currently, are, and will likely continue to be subject to claims, litigation, and other actions, including potential regulatory proceedings, involving patent and other intellectual property matters, taxes, labor and employment, competition and antitrust, commercial disputes, goods and services offered by us and by third parties, and other matters. There are many uncertainties associated with any litigation or investigation, and we cannot be certain that these actions or other third-party claims against us will be resolved without litigation, fines and/or substantial
settlement payments or judgements. If information becomes available that causes us to determine that a loss in any of our pending litigation, investigations or settlements is probable, and we can reasonably estimate the loss associated with such events, we will record the loss in accordance with U.S. GAAP. However, the actual liability in any such litigation or investigation may be materially different from our estimates, which could require us to record additional costs.
Foreign Currency Remeasurement
We use the United States dollar as our functional currency for all of our subsidiaries. Foreign currency monetary assets and liabilities are remeasured into United States dollars at end-of-period exchange rates. Non-monetary assets and liabilities such as property and equipment and equity are remeasured at historical exchange rates. Revenue and expenses are remeasured at exchange rates in effect during each period, except for those expenses related to non-monetary balance sheet amounts, which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in earnings in our Consolidated Statements of Income and to date have not been significant.
Income Taxes
We recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized.
Our calculation of deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. Our estimates of deferred tax assets and liabilities may change based, in part, on added certainty or finality to an anticipated outcome, changes in accounting standards or tax laws in the United States, or foreign jurisdictions where we operate, or changes in other facts or circumstances. In addition, we recognize liabilities for potential United States and foreign income tax contingencies based on our estimate of whether, and the extent to which, additional taxes may be due. If we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly.
As of January 30, 2022, we had a valuation allowance of $907 million related to state and certain other deferred tax assets that management determined are not likely to be realized due to jurisdictional projections of future taxable income, tax attributes usage limitation by certain jurisdictions, and potential utilization limitations of tax attributes acquired as a result of stock ownership changes. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as an income tax benefit during the period.
We recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.
Net Income Per Share
Basic net income per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common and potentially dilutive shares outstanding during the period, using the treasury stock method. Under the treasury stock method, the effect of equity awards outstanding is not included in the computation of diluted net income per share for periods when their effect is anti-dilutive.
Cash and Cash Equivalents and Marketable Securities
We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased. We currently classify our investments as current based on the nature of the investments and their availability for use in current operations.
We classify our cash equivalents and marketable securities related to debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of
tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the other income (expense), net, section of our Consolidated Statements of Income.
All of our available-for-sale debt investments are subject to a periodic impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or we intend to sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the other income (expense), net section of our Consolidated Statements of Income.
Fair Value of Financial Instruments
The carrying value of cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their relatively short maturities as of January 30, 2022 and January 31, 2021. Marketable securities are comprised of available-for-sale securities that are reported at fair value with the related unrealized gains or losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. Fair value of the marketable securities is determined based on quoted market prices. Derivative instruments are recognized as either assets or liabilities and are measured at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. For derivative instruments designated as fair value hedges, the gains or losses are recognized in earnings in the periods of change together with the offsetting losses or gains on the hedged items attributed to the risk being hedged. For derivative instruments designated as cash-flow hedges, the effective portion of the gains or losses on the derivatives is initially reported as a component of other comprehensive income or loss and is subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments not designated for hedge accounting, changes in fair value are recognized in earnings.
Concentration of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, marketable securities, and accounts receivable. Our investment policy requires the purchase of highly-rated fixed income securities, the diversification of investment type and credit exposures, and includes certain limits on our portfolio duration. We perform ongoing credit evaluations of our customers’ financial condition and maintain an allowance for potential credit losses. This allowance consists of an amount identified for specific customers and an amount based on overall estimated exposure. Our overall estimated exposure excludes amounts covered by credit insurance and letters of credit.
Inventories
Inventory cost is computed on an adjusted standard basis, which approximates actual cost on an average or first-in, first-out basis. Inventory costs consist primarily of the cost of semiconductors, including wafer fabrication, assembly, testing and packaging, manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, and shipping costs, as well as the cost of purchased memory products and other component parts. We charge cost of sales for inventory provisions to write-down our inventory to the lower of cost or net realizable value or for obsolete or excess inventory. Most of our inventory provisions relate to excess quantities of products, based on our inventory levels and future product purchase commitments compared to assumptions about future demand and market conditions. Once inventory has been written-off or written-down, it creates a new cost basis for the inventory that is not subsequently written-up. We record a liability for noncancelable purchase commitments with suppliers for quantities in excess of our future demand forecasts consistent with our valuation of obsolete or excess inventory.
Property and Equipment
Property and equipment are stated at cost. Depreciation of property and equipment is computed using the straight-line method based on the estimated useful lives of the assets, generally three to five years. Once an asset is identified for retirement or disposition, the related cost and accumulated depreciation or amortization are removed, and a gain or loss is recorded. The estimated useful lives of our buildings are up to thirty years. Depreciation expense includes the amortization of assets recorded under finance leases. Leasehold improvements and assets recorded under finance leases are amortized over the shorter of the expected lease term or the estimated useful life of the asset.
Leases
We determine if an arrangement is or contains a lease at inception. Operating leases with lease terms of more than 12 months are included in operating lease assets, accrued and other current liabilities, and long-term operating lease liabilities on our consolidated balance sheet. Operating lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term.
Operating lease assets and liabilities are recognized based on the present value of the remaining lease payments discounted using our incremental borrowing rate. Operating lease assets also include initial direct costs incurred and prepaid lease payments, minus any lease incentives. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.
We combine the lease and non-lease components in determining the operating lease assets and liabilities.
Goodwill
Goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier if indicators of potential impairment exist. For the purposes of completing our impairment test, we perform either a qualitative or a quantitative analysis on a reporting unit basis. 
Qualitative factors include industry and market considerations, overall financial performance, and other relevant events and factors affecting the reporting units.
Our quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit’s fair value. The income and market valuation approaches consider a number of factors that include, but are not limited to, prospective financial information, growth rates, residual values, discount rates and comparable multiples from publicly traded companies in our industry and require us to make certain assumptions and estimates regarding industry economic factors and the future profitability of our business. 
Intangible Assets and Other Long-Lived Assets
Intangible assets primarily represent acquired intangible assets including developed technology, in-process research and development, or IPR&D, and customer relationships, as well as rights acquired under technology licenses, patents, and acquired IP. We currently amortize our intangible assets with finite lives over periods ranging from one to twenty years using a method that reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up or, if that pattern cannot be reliably determined, using a straight-line amortization method. We initially capitalize the fair value of IPR&D as an intangible asset with an indefinite life. When IPR&D projects are completed, we reclassify the IPR&D as an amortizable purchased intangible asset and amortize over the asset’s estimated useful life.
Long-lived assets, such as property and equipment and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of assets or asset groups to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset or asset group exceeds the estimated fair value of the asset or asset group. Fair value is determined based on the estimated discounted future cash flows expected to be generated by the asset or asset group. Assets and liabilities to be disposed of would be separately presented in the Consolidated Balance Sheet and the assets would be reported at the lower of the carrying amount or fair value less costs to sell, and would no longer be depreciated.
Business Combination
We allocate the fair value of the purchase price of an acquisition to the tangible assets acquired, liabilities assumed, and intangible assets acquired, including IPR&D, based on their estimated fair values. The excess of the fair value of the purchase price over the fair values of these net tangible and intangible assets acquired is recorded as goodwill. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but our estimates and assumptions are inherently uncertain and subject to refinement. The estimates and assumptions used in valuing intangible assets include, but are not limited to, the amount and timing of projected future cash flows, discount rate used
to determine the present value of these cash flows and asset lives. These estimates are inherently uncertain and, therefore, actual results may differ from the estimates made. As a result, during the measurement period of up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of the purchase price of an acquisition, whichever comes first, any subsequent adjustments are recorded to our Consolidated Statements of Income.
Acquisition-related expenses are recognized separately from the business combination and expensed as incurred.
Investment in Non-Affiliated Entities
Non-marketable equity investments in privately-held companies are recorded at fair value on a non-recurring basis only if an impairment or observable price adjustment occurs in the period with changes in fair value recorded through net income. These investments are valued using observable and unobservable inputs or data in an inactive market and the valuation requires our judgment due to the absence of market prices and inherent lack of liquidity. The estimated fair value is based on quantitative and qualitative factors including subsequent financing activities by the investee.
Marketable equity investments in publicly-held companies are recorded at fair value with the related unrealized and realized gains and losses recognized in other income (expense), net.
Adoption of New and Recently Issued Accounting Pronouncements
Recently Adopted Accounting Pronouncement
In October 2021, the Financial Accounting Standards Board issued a new accounting standard to require that an acquirer recognize and measure contract assets and liabilities acquired in a business combination in accordance with Accounting Standards Codification 606, Revenue from Contracts with Customers. We early adopted this accounting standard in the third quarter of fiscal year 2022 and the impact was immaterial.
v3.22.0.1
Business Combination
12 Months Ended
Jan. 30, 2022
Business Combination and Asset Acquisition [Abstract]  
Business Combination Business Combination
Termination of the Arm Share Purchase Agreement
On February 8, 2022, NVIDIA and SoftBank announced the termination of the Share Purchase Agreement whereby NVIDIA would have acquired Arm from SoftBank. The parties agreed to terminate because of significant regulatory challenges preventing the completion of the transaction. We intend to record in operating expenses a $1.36 billion charge in the first quarter of fiscal year 2023 reflecting the write-off of the prepayment provided at signing in September 2020.
Acquisition of Mellanox Technologies, Ltd.
In April 2020, we completed the acquisition of all outstanding shares of Mellanox for a total purchase consideration of $7.13 billion. Mellanox is a supplier of high-performance interconnect products for computing, storage and communications applications. We acquired Mellanox to optimize data center workloads to scale across the entire computing, networking, and storage stack.
Purchase Price Allocation
The aggregate purchase consideration has been allocated as follows (in millions):
Purchase Price
Cash paid for outstanding Mellanox ordinary shares (1)$7,033 
Cash for Mellanox equity awards (2)16 
Total cash consideration7,049 
Fair value of Mellanox equity awards assumed by NVIDIA (3)85 
Total purchase consideration$7,134 
Allocation
Cash and cash equivalents$115 
Marketable securities699 
Accounts receivable, net216 
Inventories320 
Prepaid expenses and other assets179 
Property and equipment, net144 
Goodwill3,431 
Intangible assets2,970 
Accounts payable(136)
Accrued and other current liabilities(236)
Income tax liability(191)
Deferred income tax liability(258)
Other long-term liabilities(119)
$7,134 

(1)    Represents the cash consideration of $125.00 per share paid to Mellanox shareholders for approximately 56 million shares of outstanding Mellanox ordinary shares.
(2)    Represents the cash consideration for the settlement of approximately 249 thousand Mellanox stock options held by employees and non-employee directors of Mellanox.
(3)    Represents the fair value of Mellanox’s stock-based compensation awards attributable to pre-combination services.

We allocated the purchase price to tangible and identified intangible assets acquired and liabilities assumed based on the estimated fair values.
The goodwill is primarily attributable to the planned growth in the combined business of NVIDIA and Mellanox. Goodwill is not amortized to earnings, but instead is reviewed for impairment at least annually, absent any interim indicators of impairment. Goodwill recognized in the acquisition is not expected to be deductible for foreign tax purposes. Goodwill arising from the Mellanox acquisition has been allocated to the Compute and Networking segment. Refer to Note 17 – Segment Information for further details on segments.
The operating results of Mellanox have been included in our consolidated financial statements for fiscal year 2021 since the acquisition date of April 27, 2020. Revenue attributable to Mellanox was approximately 10% for fiscal year 2021. There is not a practical way to determine net income attributable to Mellanox due to integration. Acquisition-related costs attributable to Mellanox of $28 million were included in selling, general and administrative expense for fiscal year 2021.
Intangible Assets
The estimated fair value and useful life of the acquired intangible assets at the time of the acquisition are as follows:
Fair ValueUseful Lives
(In millions)
Developed technology (1)$1,640 5 years
Customer relationships (2)440 3 years
Order backlog (3)190 Based on actual shipments
Trade names (4)70 5 years
Total identified finite-lived intangible assets2,340 
IPR&D (5)630 N/A
Total identified intangible assets$2,970 

(1)    The fair value of developed technology was identified using the Multi-Period Excess Earnings Method.
(2)    Customer relationships represent the fair value of the existing relationships using the With and Without Method.
(3)    Order backlog represents primarily the fair value of purchase arrangements with customers using the Multi-Period Excess Earnings Method. The intangible asset was fully amortized as of January 31, 2021.
(4)    Trade names primarily relate to Mellanox trade names and fair value was determined by applying the Relief-from-Royalty Method under the income approach.
(5)    The fair value of IPR&D was determined using the Multi-Period Excess Earnings Method.

The fair value of the finite-lived intangible assets will be amortized over the estimated useful lives based on the pattern in which the economic benefits are expected to be received to cost of revenue and operating expenses.
Mellanox has an IPR&D project associated with the next generation interconnect product that had not yet reached technological feasibility as of the acquisition date. Accordingly, we recorded an indefinite-lived intangible asset of $630 million for the fair value of this project, which was initially not amortized. Instead, the project is tested for impairment annually and whenever events or changes in circumstances indicate that the project may be impaired or may have reached technological feasibility. Once and if the project reaches technological feasibility, we will begin to amortize the intangible asset over its estimated useful life.
Supplemental Unaudited Pro Forma Information
The following unaudited pro forma financial information summarizes the combined results of operations for NVIDIA and Mellanox as if the companies were combined as of the beginning of fiscal year 2020:
Pro Forma
 Year Ended
 January 31, 2021January 26, 2020
(In millions)
Revenue$17,104 $12,250 
Net income$4,757 $2,114 
The unaudited pro forma information includes adjustments related to amortization of acquired intangible assets, adjustments to stock-based compensation expense, fair value of acquired inventory, and transaction costs. The unaudited pro forma information presented above is for informational purposes only and is not necessarily indicative of our consolidated results of operations of the combined business had the acquisition actually occurred at the beginning of fiscal year 2020 or of the results of our future operations of the combined businesses.
The pro forma results reflect the inventory step-up expense of $161 million in the fiscal year 2020 and were excluded from the pro forma results for fiscal year 2021. There were no other material nonrecurring adjustments.
v3.22.0.1
Leases
12 Months Ended
Jan. 30, 2022
Leases [Abstract]  
Leases Leases
Our lease obligations primarily consist of operating leases for our headquarters complex, domestic and international office facilities, and data center space, with lease periods expiring between fiscal years 2023 and 2035.
Future minimum lease payments under our non-cancelable operating leases as of January 30, 2022, are as follows:
Operating Lease Obligations
 (In millions)
Fiscal Year: 
2023$176 
2024162 
2025136 
2026124 
2027114 
2028 and thereafter288 
Total1,000 
Less imputed interest115 
Present value of net future minimum lease payments885 
Less short-term operating lease liabilities144 
Long-term operating lease liabilities$741 
In addition to our existing operating lease obligations, we have operating leases that are expected to commence within fiscal year 2023 with lease terms of 7 years for $169 million.

Operating lease expense for fiscal years 2022, 2021, and 2020 was $168 million, $145 million, $114 million, respectively. Short-term and variable lease expenses for fiscal years 2022, 2021, and 2020 were not significant.

Other information related to leases was as follows:
Year Ended
January 30, 2022January 31, 2021January 26, 2020
 (In millions)
Supplemental cash flows information 
Operating cash flows used for operating leases$154 $141 $103 
Operating lease assets obtained in exchange for lease obligations (1)$266 $200 $238 
(1)    Fiscal year 2021 includes $80 million of operating lease assets addition due to Mellanox.
As of January 30, 2022, our operating leases had a weighted average remaining lease term of 7.1 years and a weighted average discount rate of 2.51%. As of January 31, 2021, our operating leases had a weighted average remaining lease term of 7.6 years and a weighted average discount rate of 2.87%.
v3.22.0.1
Stock-Based Compensation
12 Months Ended
Jan. 30, 2022
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based CompensationOur stock-based compensation expense is associated with restricted stock units, or RSUs, performance stock units that are based on our corporate financial performance targets, or PSUs, performance stock units that are based on market conditions, or market-based PSUs, and our ESPP.
Our Consolidated Statements of Income include stock-based compensation expense, net of amounts allocated to inventory, as follows:
 Year Ended
January 30,
2022
January 31,
2021
January 26,
2020
 (In millions)
Cost of revenue$141 $88 $39 
Research and development1,298 860 540 
Sales, general and administrative565 449 265 
Total$2,004 $1,397 $844 
Stock-based compensation capitalized in inventories was not significant during fiscal years 2022, 2021, and 2020.
The following is a summary of equity awards granted under our equity incentive plans:
Year Ended
January 30,
2022
January 31,
2021
January 26,
2020
(In millions, except per share data)
RSUs, PSUs and Market-based PSUs
Awards granted18 36 28 
Estimated total grant-date fair value$3,492 $2,764 $1,282 
Weighted average grant-date fair value per share$190.69 $76.81 $46.12 
ESPP
Shares purchased
Weighted average price per share$56.36 $34.80 $37.19 
Weighted average grant-date fair value per share$23.24 $16.91 $16.22 
As of January 30, 2022, there was $4.87 billion of aggregate unearned stock-based compensation expense, net of forfeitures. This amount is expected to be recognized over a weighted average period of 2.4 years for RSUs, PSUs, and market-based PSUs, and 0.9 years for ESPP.
The fair value of shares issued under our ESPP have been estimated with the following assumptions:
 Year Ended
 January 30,
2022
January 31,
2021
January 26,
2020
(Using the Black-Scholes model)
ESPP
Weighted average expected life (in years)
0.1-2.0
0.1-2.0
0.1-2.0
Risk-free interest rate
—%-0.5%
0.1%-1.6%
1.5%-2.6%
Volatility
20%-58%
26%-89%
30%-82%
Dividend yield
0.1%
0.1%-0.3%
0.3%-0.4%
For ESPP shares, the expected term represents the average term from the first day of the offering period to the purchase date. The risk-free interest rate assumption used to value ESPP shares is based upon observed interest rates on Treasury bills appropriate for the expected term. Our expected stock price volatility assumption for ESPP is estimated using historical volatility. For awards granted, we use the dividend yield at grant date. Our RSU, PSU, and market-based PSU awards are not eligible for cash dividends prior to vesting; therefore, the fair values of RSUs, PSUs, and market-based PSUs are discounted for the dividend yield.
Additionally, for RSU, PSU, and market-based PSU awards, we estimate forfeitures semi-annually and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates. Forfeitures are estimated based on historical experience.
Equity Incentive Program
We grant or have granted stock options, RSUs, PSUs, market-based PSUs, and stock purchase rights under the following equity incentive plans. In addition, in connection with our acquisitions of various companies, we have assumed certain stock-based awards granted under their stock incentive plans and converted them into our RSUs.
Amended and Restated 2007 Equity Incentive Plan
In 2007, our shareholders approved the NVIDIA Corporation 2007 Equity Incentive Plan, as most recently amended and restated, or the 2007 Plan.
The 2007 Plan authorizes the issuance of incentive stock options, non-statutory stock options, restricted stock, restricted stock units, stock appreciation rights, performance stock awards, performance cash awards, and other stock-based awards to employees, directors and consultants. Only our employees may receive incentive stock options. As of January 30, 2022, up to 50 million shares of our common stock could be issued pursuant to stock awards granted under the 2007 Plan, of which 6 million shares were issuable upon the exercise of outstanding stock options. All options are fully vested, the last of which will expire by December 2023 if not exercised. Currently, we grant RSUs, PSUs and market-based PSUs under the 2007 Plan, under which, as of January 30, 2022, there were 131 million shares available for future grants.
Subject to certain exceptions, RSUs granted to employees either vest (A) over a four-year period, subject to continued service, with 25% vesting on a pre-determined date that is close to the anniversary of the date of grant and 6.25% vesting quarterly thereafter, or (B) over a three-year period, subject to continued service, with 40% vesting on a pre-determined date that is close to the anniversary of the date of grant and 7.5% vesting quarterly thereafter. PSUs vest over a four-year period, subject to continued service, with 25% vesting on a pre-determined date that is close to the anniversary of the date of grant and 6.25% vesting quarterly thereafter. Market-based PSUs vest 100% on approximately the three-year anniversary of the date of grant. However, the number of shares subject to both PSUs and market-based PSUs that are eligible to vest is generally determined by the Compensation Committee based on achievement of pre-determined criteria.
Amended and Restated 2012 Employee Stock Purchase Plan
In 2012, our shareholders approved the NVIDIA Corporation 2012 Employee Stock Purchase Plan, as most recently amended and restated, or the 2012 Plan.
Employees who participate in the 2012 Plan may have up to 15% of their earnings withheld to purchase shares of common stock. The Board may decrease this percentage at its discretion. Each offering period is approximately 24 months, which is generally divided into four purchase periods of six months. The price of common stock purchased under our 2012 Plan will be equal to 85% of the lower of the fair market value of the common stock on the commencement date of each offering period or the fair market value of the common stock on each purchase date within the offering. As of January 30, 2022, we had 233 million shares reserved for future issuance under the 2012 Plan.
Equity Award Activity
The following is a summary of our equity award transactions under our equity incentive plans: 
RSUs, PSUs and Market-based PSUs Outstanding
 Number of SharesWeighted Average Grant-Date Fair Value
(In millions, except per share data)
Balances, January 31, 202159 $66.17 
Granted18 $190.69 
Vested restricted stock(29)$66.67 
Canceled and forfeited(2)$86.47 
Balances, January 30, 202246 $114.19 
Vested and expected to vest after January 30, 202246 $113.84 

As of January 30, 2022 and January 31, 2021, there were 131 million and 148 million shares, respectively, of common stock available for future grants under our equity incentive plans. 
As of January 30, 2022, the total intrinsic value of options currently exercisable and outstanding was $1.38 billion, with an average exercise price of $3.55 per share and an average remaining term of 1.1 years. The total intrinsic value of options exercised was $741 million, $521 million, and $84 million for fiscal years 2022, 2021, and 2020, respectively. Upon the exercise of an option, we issue new shares of stock.
The total fair value of RSUs and PSUs, as of their respective vesting dates, during the years ended January 30, 2022, January 31, 2021, and January 26, 2020, was $5.56 billion, $2.67 billion, and $1.45 billion, respectively.
v3.22.0.1
Net Income Per Share
12 Months Ended
Jan. 30, 2022
Earnings Per Share [Abstract]  
Net Income Per Share Net Income Per Share
The following is a reconciliation of the denominator of the basic and diluted net income per share computations for the periods presented:
 Year Ended
 January 30,
2022
January 31,
2021
January 26,
2020
 (In millions, except per share data)
Numerator:   
Net income$9,752 $4,332 $2,796 
Denominator:   
Basic weighted average shares2,496 2,467 2,439 
Dilutive impact of outstanding equity awards39 43 33 
Diluted weighted average shares2,535 2,510 2,472 
Net income per share:   
Basic (1)$3.91 $1.76 $1.15 
Diluted (2)$3.85 $1.73 $1.13 
Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive
21 12 44 
(1)    Calculated as net income divided by basic weighted average shares.
(2)    Calculated as net income divided by diluted weighted average shares.
v3.22.0.1
Goodwill
12 Months Ended
Jan. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill GoodwillAs of January 30, 2022, the total carrying amount of goodwill was $4.35 billion, consisting of goodwill balances allocated to our Graphics and Compute & Networking reporting units of $361 million and $3.99 billion, respectively. As of January 31, 2021, the total carrying amount of goodwill was $4.19 billion, consisting of goodwill balances allocated to our Graphics and Compute & Networking reporting units of $347 million and $3.85 billion, respectively. Goodwill increased by $156 million in fiscal year 2022 from acquisitions. We assigned $143 million of the increase in goodwill to our Compute & Networking segment and assigned $13 million of the increase to our Graphics segment. During the fourth quarters of fiscal years 2022, 2021, and 2020, we completed our annual impairment tests and concluded that goodwill was not impaired in any of these years.
v3.22.0.1
Amortizable Intangible Assets
12 Months Ended
Jan. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Amortizable Intangible Assets Amortizable Intangible Assets
The components of our amortizable intangible assets are as follows:
 January 30, 2022January 31, 2021
 
Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
 (In millions)(In millions)
Acquisition-related intangible assets (1)$3,418 $(1,304)$2,114 $3,280 $(774)$2,506 
Patents and licensed technology717 (492)225 706 (475)231 
Total intangible assets$4,135 $(1,796)$2,339 $3,986 $(1,249)$2,737 
(1)    As of January 30, 2022, acquisition-related intangible assets include the fair value of a Mellanox in-process research and development project of $630 million, which has not yet commenced amortization.
Amortization expense associated with intangible assets for fiscal years 2022, 2021, and 2020 was $563 million, $612 million, and $25 million, respectively. Future amortization expense related to the net carrying amount of intangible assets, excluding in-process research and development, as of January 30, 2022 is estimated to be $585 million in fiscal year 2023, $461 million in fiscal year 2024, $405 million in fiscal year 2025, $121 million in fiscal year 2026, $16 million in fiscal year 2027, and $121 million in fiscal year 2028 and thereafter.
v3.22.0.1
Cash Equivalents and Marketable Securities
12 Months Ended
Jan. 30, 2022
Investments, Debt and Equity Securities [Abstract]  
Cash Equivalents and Marketable Securities Cash Equivalents and Marketable SecuritiesOur cash equivalents and marketable securities related to debt securities are classified as “available-for-sale” debt securities.
The following is a summary of cash equivalents and marketable securities as of January 30, 2022 and January 31, 2021:
 January 30, 2022
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$9,977 $— $(3)$9,974 $1,102 $8,872 
Debt securities issued by the United States Treasury7,314 — (14)7,300 — 7,300 
Debt securities issued by United States government agencies1,612 — — 1,612 256 1,356 
Certificates of deposit1,561 — — 1,561 21 1,540 
Money market funds316 — — 316 316 — 
Foreign government bonds150 — — 150 — 150 
Total$20,930 $— $(17)$20,913 $1,695 $19,218 
 January 31, 2021
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$4,442 $$— $4,444 $234 $4,210 
Debt securities issued by United States government agencies2,975 — 2,976 28 2,948 
Debt securities issued by the United States Treasury2,846 — — 2,846 25 2,821 
Certificates of deposit705 — — 705 37 668 
Money market funds313 — — 313 313 — 
Foreign government bonds67 — — 67 — 67 
Total$11,348 $$— $11,351 $637 $10,714 
The following table provides the breakdown of unrealized losses as of January 30, 2022, aggregated by investment category and length of time that individual securities have been in a continuous loss position:
 Less than 12 Months12 Months or GreaterTotal
 Estimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized Loss
 (In millions)
Corporate debt securities$2,445 $(3)$19 $— $2,464 $(3)
Debt securities issued by the United States Treasury5,292 (14)— — 5,292 (14)
Total$7,737 $(17)$19 $— $7,756 $(17)
Net realized gains and unrealized gains and losses were not significant for all periods presented.
The amortized cost and estimated fair value of cash equivalents and marketable securities as of January 30, 2022 and January 31, 2021 are shown below by contractual maturity.
 January 30, 2022January 31, 2021
 Amortized
Cost
Estimated
Fair Value
Amortized
Cost
Estimated
Fair Value
 (In millions)
Less than one year$16,346 $16,343 $10,782 $10,783 
Due in 1 - 5 years4,584 4,570 566 568 
Total$20,930 $20,913 $11,348 $11,351 
v3.22.0.1
Fair Value of Financial Assets and Liabilities
12 Months Ended
Jan. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value of Financial Assets and Liabilities Fair Value of Financial Assets and LiabilitiesThe fair values of our financial assets and liabilities are determined using quoted market prices of identical assets or quoted market prices of similar assets from active markets. We review fair value hierarchy classification on a quarterly basis.
Fair Value at
Pricing CategoryJanuary 30, 2022January 31, 2021
(In millions)
Assets
Cash equivalents and marketable securities:
Money market fundsLevel 1$316 $313 
Corporate debt securitiesLevel 2$9,974 $4,444 
Debt securities issued by the United States TreasuryLevel 2$7,300 $2,846 
Debt securities issued by United States government agenciesLevel 2$1,612 $2,976 
Certificates of depositLevel 2$1,561 $705 
Foreign government bondsLevel 2$150 $67 
Other assets (Investment in non-affiliated entities):
Publicly-held equity securities (1)Level 1$58 $— 
Privately-held equity securitiesLevel 3$208 $144 
Liabilities (2)
2.20% Notes Due 2021
Level 2$— $1,011 
0.309% Notes Due 2023
Level 2$1,236 $— 
0.584% Notes Due 2024
Level 2$1,224 $— 
3.20% Notes Due 2026
Level 2$1,055 $1,124 
1.55% Notes Due 2028
Level 2$1,200 $— 
2.85% Notes Due 2030
Level 2$1,542 $1,654 
2.00% Notes Due 2031
Level 2$1,200 $— 
3.50% Notes Due 2040
Level 2$1,066 $1,152 
3.50% Notes Due 2050
Level 2$2,147 $2,308 
3.70% Notes Due 2060
Level 2$551 $602 
(1)    Unrealized gains of $48 million from an investment in a publicly-traded equity security were recorded in other income (expense), net, in fiscal year 2022.
(2)    These liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs.
v3.22.0.1
Balance Sheet Components
12 Months Ended
Jan. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
Certain balance sheet components are as follows:
 January 30,
2022
January 31,
2021
(In millions)
Inventories:
Raw materials$791 $632 
Work in-process692 457 
Finished goods1,122 737 
Total inventories$2,605 $1,826 

 January 30,
2022
January 31,
2021
Estimated
Useful Life
(In millions)(In years)
Property and Equipment:
Land$218 $218 (A)
Buildings, leasehold improvements, and furniture874 796 (B)
Equipment, compute hardware, and software2,852 1,985 
3-5
Construction in process737 558 (C)
Total property and equipment, gross4,681 3,557  
Accumulated depreciation and amortization(1,903)(1,408) 
Total property and equipment, net$2,778 $2,149  
(A)Land is a non-depreciable asset.
(B)The estimated useful lives of our buildings are up to thirty years. Leasehold improvements and finance leases are amortized based on the lesser of either the asset’s estimated useful life or the expected lease term.
(C)Construction in process represents assets that are not available for their intended use as of the balance sheet date.
Depreciation expense for fiscal years 2022, 2021, and 2020 was $611 million, $486 million, and $355 million, respectively.
Accumulated amortization of leasehold improvements and finance leases was $265 million and $223 million as of January 30, 2022 and January 31, 2021, respectively.
Property, equipment and intangible assets acquired by assuming related liabilities during fiscal years 2022, 2021, and 2020 were $258 million, $157 million, and $212 million, respectively.
 January 30,
2022
January 31,
2021
Other assets:(In millions)
Prepaid supply agreements$1,747 $— 
Advanced consideration for acquisition (1)1,357 1,357 
Prepaid royalties409 440 
Investment in non-affiliated entities266 144 
Other62 203 
Total other assets$3,841 $2,144 
(1)Refer to Note 2 - Business Combination for further details on the Arm acquisition.
 January 30,
2022
January 31,
2021
(In millions)
Accrued and Other Current Liabilities:
Customer program accruals$1,000 $630 
Accrued payroll and related expenses409 297 
Deferred revenue (1)300 288 
Excess inventory purchase obligations196 52 
Other647 510 
Total accrued and other current liabilities$2,552 $1,777 
(1)Deferred revenue primarily includes customer advances and deferrals related to license and development arrangements, support for hardware and software, and cloud services.
 January 30,
2022
January 31,
2021
(In millions)
Other Long-Term Liabilities:
Income tax payable (1)$980 $836 
Deferred income tax245 241 
Deferred revenue (2)202 163 
Other126 135 
Total other long-term liabilities$1,553 $1,375 
(1)As of January 30, 2022, income tax payable represents the long-term portion of the one-time transition tax payable of $251 million, long-term portion of the unrecognized tax benefits of $670 million, and related interest and penalties of $59 million.
(2)Deferred revenue primarily includes deferrals related to support for hardware and software.
Deferred Revenue
The following table shows the changes in deferred revenue during fiscal years 2022 and 2021.
 January 30,
2022
January 31,
2021
(In millions)
Balance at beginning of period$451 $201 
Deferred revenue added during the period821 536 
Addition due to business combinations75 
Revenue recognized during the period(778)(361)
Balance at end of period$502 $451 
Revenue related to remaining performance obligations represents the contracted license and development arrangements and support for hardware and software. This includes deferred revenue currently recorded and amounts that will be invoiced in future periods. As of January 30, 2022, $624 million of revenue related to performance obligations had not been recognized, of which we expect to recognize approximately 49% over the next twelve months and the remainder thereafter. This excludes revenue related to performance obligations for contracts with a length of one year or less.
v3.22.0.1
Derivative Financial Instruments
12 Months Ended
Jan. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
We enter into foreign currency forward contracts to mitigate the impact of foreign currency exchange rate movements on our operating expenses. These contracts are designated as cash flow hedges for hedge accounting treatment. Gains or losses on the contracts are recorded in accumulated other comprehensive income or loss and reclassified to operating expense when the related operating expenses are recognized in earnings or ineffectiveness should occur. The fair value of the contracts was not significant as of January 30, 2022 and January 31, 2021.
We enter into foreign currency forward contracts to mitigate the impact of foreign currency movements on monetary assets and liabilities that are denominated in currencies other than U.S. dollar. These forward contracts were not designated for hedge accounting treatment. Therefore, the change in fair value of these contracts is recorded in other income or expense and offsets the change in fair value of the hedged foreign currency denominated monetary assets and liabilities, which is also recorded in other income or expense.
The table below presents the notional value of our foreign currency forward contracts outstanding as of January 30, 2022 and January 31, 2021:
January 30,
2022
January 31,
2021
 (In millions)
Designated as cash flow hedges$1,023 $840 
Non-designated hedges$408 $441 
As of January 30, 2022, all designated foreign currency forward contracts mature within eighteen months. The expected realized gains and losses deferred into accumulated other comprehensive income (loss) related to foreign currency forward contracts within the next twelve months was not significant.
During fiscal years 2022 and 2021, the impact of derivative financial instruments designated for hedge accounting treatment on other comprehensive income or loss was not significant and all such instruments were determined to be highly effective.
v3.22.0.1
Debt
12 Months Ended
Jan. 30, 2022
Debt Disclosure [Abstract]  
Debt Debt
Long-Term Debt
In June 2021, March 2020, and September 2016, we issued a total of $5.00 billion, $5.00 billion, and $2.00 billion aggregate principal of senior notes, respectively. The net proceeds from these offerings were $4.98 billion, $4.97 billion, and $1.98 billion, respectively, after deducting debt discount and issuance costs.
On August 16, 2021, we repaid the $1.00 billion of 2.20% Notes Due 2021.
All of our notes are unsecured senior obligations. All existing and future liabilities of our subsidiaries will be effectively senior to the notes. Our notes pay interest semi-annually. We may redeem each of our notes prior to maturity, subject to a make-whole premium as defined in the applicable form of note.
The carrying value of the Notes, the calendar year of maturity, and the associated interest rates were as follows:
 Expected
Remaining Term (years)
Effective
Interest Rate
January 30,
2022
January 31,
2021
   (In millions)
2.20% Notes Due 2021
2.38%$— $1,000 
0.309% Notes Due 2023
1.40.41%1,250 — 
0.584% Notes Due 2024
2.40.66%1,250 — 
3.20% Notes Due 2026
4.63.31%1,000 1,000 
1.55% Notes Due 2028
6.41.64%1,250 — 
2.85% Notes Due 2030
8.22.93%1,500 1,500 
2.00% Notes Due 2031
9.42.09%1,250 — 
3.50% Notes Due 2040
18.23.54%1,000 1,000 
3.50% Notes Due 2050
28.23.54%2,000 2,000 
3.70% Notes Due 2060
38.23.73%500 500 
Unamortized debt discount and issuance costs  (54)(37)
Net carrying amount  10,946 6,963 
Less short-term portion— (999)
Total long-term portion$10,946 $5,964 
As of January 30, 2022, we were in compliance with the required covenants under the Notes.
Commercial Paper
We have a $575 million commercial paper program to support general corporate purposes. As of January 30, 2022, we had not issued any commercial paper.
v3.22.0.1
Commitments and Contingencies
12 Months Ended
Jan. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Purchase Obligations
Our purchase obligations primarily include our commitments to purchase components used to manufacture our products, including long-term supply agreements, certain software and technology licenses, other goods and services and long-lived assets.
We have entered into several long-term supply agreements, under which we have made advance payments and have $1.58 billion remaining unpaid. As of January 30, 2022, we had outstanding inventory purchase and long-term supply obligations totaling $9.00 billion, inclusive of the $1.58 billion, and other purchase obligations totaling $1.30 billion.
Total future unconditional purchase commitments as of January 30, 2022, are as follows:
Commitments
 (In millions)
Fiscal Year: 
2023$9,302 
2024765 
2025201 
202628 
Total$10,296 
In March 2022, we entered into a supply agreement with payments of $670 million to be paid over nine years.
Accrual for Product Warranty Liabilities
The estimated amount of product warranty liabilities was $46 million and $22 million as of January 30, 2022 and January 31, 2021, respectively.
In connection with certain agreements that we have entered in the past, we have provided indemnities for matters such as tax, product, and employee liabilities. We have included IP indemnification provisions in our technology related agreements with third parties. Maximum potential future payments cannot be estimated because many of these agreements do not have a maximum stated liability. We have not recorded any liability for such indemnifications.
Litigation
Securities Class Action and Derivative Lawsuits
The plaintiffs in the putative securities class action lawsuit, captioned 4:18-cv-07669-HSG, initially filed on December 21, 2018 in the United States District Court for the Northern District of California, and titled In Re NVIDIA Corporation Securities Litigation, filed an amended complaint on May 13, 2020. The amended complaint asserted that NVIDIA and certain NVIDIA executives violated Section 10(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and SEC Rule 10b-5, by making materially false or misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand between May 10, 2017 and November 14, 2018. Plaintiffs also alleged that the NVIDIA executives who they named as defendants violated Section 20(a) of the Exchange Act. Plaintiffs sought class certification, an award of unspecified compensatory damages, an award of reasonable costs and expenses, including attorneys’ fees and expert fees, and further relief as the Court may deem just and proper. On March 2, 2021, the district court granted NVIDIA’s motion to dismiss the complaint without leave to amend, entered judgment in favor of NVIDIA and closed the case. On March 30, 2021, plaintiffs filed an appeal from judgment in the United States Court of Appeals for the Ninth Circuit, case number 21-15604. Oral argument is scheduled for May 10, 2022.
The putative derivative lawsuit pending in the United States District Court for the Northern District of California, captioned 4:19-cv-00341-HSG, initially filed January 18, 2019 and titled In re NVIDIA Corporation Consolidated Derivative Litigation, was stayed pending resolution of the plaintiffs’ appeal in the In Re NVIDIA Corporation Securities Litigation action. On February 22, 2022, the court administratively closed the case, but stated that it would reopen the case once the appeal in the In Re NVIDIA Corporation Securities Litigation action is resolved. The lawsuit asserts claims, purportedly on behalf of us, against certain officers and directors of the Company for breach of fiduciary duty, unjust enrichment, waste of corporate assets, and violations of Sections 14(a), 10(b), and 20(a) of the Exchange Act based on the dissemination of allegedly false and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs are seeking unspecified damages and other relief, including reforms and improvements to NVIDIA’s corporate governance and internal procedures.
The putative derivative actions initially filed September 24, 2019 and pending in the United States District Court for the District of Delaware, Lipchitz v. Huang, et al. (Case No. 1:19-cv-01795-UNA) and Nelson v. Huang, et. al. (Case No. 1:19-cv-01798- UNA), remain stayed pending resolution of the plaintiffs’ appeal in the In Re NVIDIA Corporation Securities Litigation action. The lawsuits assert claims, purportedly on behalf of us, against certain officers and directors of the Company for breach of fiduciary duty, unjust enrichment, insider trading, misappropriation of information, corporate waste and violations of Sections 14(a), 10(b), and 20(a) of the Exchange Act based on the dissemination of allegedly false, and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs seek unspecified damages and other relief, including disgorgement of profits from the sale of NVIDIA stock and unspecified corporate governance measures.
Accounting for Loss Contingencies
As of January 30, 2022, we have not recorded any accrual for contingent liabilities associated with the legal proceedings described above based on our belief that liabilities, while possible, are not probable. Further, except as specifically described above, any possible loss or range of loss in these matters cannot be reasonably estimated at this time. We are engaged in legal actions not described above arising in the ordinary course of business and, while there can be no assurance of favorable outcomes, we believe that the ultimate outcome of these actions will not have a material adverse effect on our operating results, liquidity or financial position.
v3.22.0.1
Income Taxes
12 Months Ended
Jan. 30, 2022
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The income tax expense (benefit) applicable to income before income taxes consists of the following:
 Year Ended
 January 30,
2022
January 31,
2021
January 26,
2020
 (In millions)
Current income taxes:   
Federal$482 $197 $65 
State42 
Foreign71 161 87 
Total current595 359 156 
Deferred taxes:   
Federal(420)(246)
Foreign14 (36)16 
Total deferred(406)(282)18 
Income tax expense$189 $77 $174 
Income before income tax consists of the following:
 Year Ended
 January 30,
2022
January 31,
2021
January 26,
2020
 (In millions)
Domestic (1)$8,446 $1,437 $620 
Foreign1,495 2,972 2,350 
Income before income tax$9,941 $4,409 $2,970 
(1)Fiscal year 2022 domestic income before income tax increased as compared to fiscal years 2021 and 2020 due to the Domestication in the second quarter of fiscal year 2022.
The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21% to income before income taxes as follows:
 Year Ended
 January 30,
2022
January 31,
2021
January 26,
2020
 (In millions)
Tax expense computed at federal statutory rate$2,088 $926 $624 
Expense (benefit) resulting from:
State income taxes, net of federal tax effect42 10 12 
Foreign-derived intangible income(520)— — 
Foreign tax rate differential(497)(561)(301)
Stock-based compensation(337)(136)(60)
U.S. federal R&D tax credit(289)(173)(110)
IP domestication(244)— — 
Other(54)11 
Income tax expense$189 $77 $174 
The tax effect of temporary differences that gives rise to significant portions of the deferred tax assets and liabilities are presented below: 
 January 30,
2022
January 31,
2021
 (In millions)
Deferred tax assets: 
Research and other tax credit carryforwards$798 $650 
Property, equipment and intangible assets530 32 
GILTI deferred tax assets378 709 
Accruals and reserves, not currently deductible for tax purposes258 59 
Operating lease liabilities125 120 
Net operating loss carryforwards118 100 
Stock-based compensation86 36 
Other deferred tax assets22 — 
Gross deferred tax assets2,315 1,706 
Less valuation allowance(907)(728)
Total deferred tax assets1,408 978 
Deferred tax liabilities:  
Acquired intangibles(169)(191)
Unremitted earnings of foreign subsidiaries(150)(111)
Operating lease assets(113)(111)
Gross deferred tax liabilities(432)(413)
Net deferred tax asset (1)$976 $565 
(1) Net deferred tax asset includes long-term deferred tax assets of $1.22 billion and $806 million and long-term deferred tax liabilities of $245 million and $241 million for fiscal years 2022 and 2021, respectively. Long-term deferred tax liabilities are included in other long-term liabilities on our Consolidated Balance Sheets.
We recognized income tax expense of $189 million, $77 million, and $174 million for fiscal years 2022, 2021, and 2020 respectively. Our annual effective tax rate was 1.9%, 1.7%, and 5.9% for fiscal years 2022, 2021, and 2020, respectively. The increase in our effective tax rate in fiscal year 2022 as compared to fiscal year 2021 was primarily due to an
increase in the amount of earnings subject to U.S. tax, and a decreased impact of tax benefits from the U.S. federal research tax credit, partially offset by the benefit of the foreign-derived intangible income deduction and the discrete benefit of the Domestication. The decrease in our effective tax rate in fiscal year 2021 as compared to fiscal year 2020 was primarily due to a decrease in the proportional amount of earnings subject to United States tax and an increase of tax benefits from stock-based compensation.
On June 28, 2021, we simplified our corporate structure by repatriating the economic rights of certain non-U.S. IP to the United States via domestication of a foreign subsidiary, or the Domestication. The Domestication more closely aligns our corporate structure to our operating structure in accordance with the Organization for Economic Cooperation and Development’s Base Erosion and Profit Shifting conclusions and changes to U.S. and European tax laws. The impact of the Domestication, which is regarded as a change in tax status, resulted in a discrete benefit primarily from re-valuing certain deferred tax assets, net of deferred tax liabilities, of $244 million in fiscal year 2022.
Our effective tax rate for fiscal year 2022 was lower than the U.S. federal statutory rate of 21% due to tax benefits from the foreign-derived intangible income deduction, income earned in jurisdictions, including the British Virgin Islands and Israel, that are subject to taxes lower than the U.S. federal statutory tax rate, excess tax benefits related to stock-based compensation, recognition of U.S. federal research tax credits and the one-time benefits of the Domestication.
Our effective tax rates for fiscal years 2021 and 2020 were lower than the U.S. federal statutory rate of 21% due primarily to income earned in jurisdictions, including the British Virgin Islands, Israel and Hong Kong, where the tax rate was lower than the U.S. federal statutory tax rate, recognition of U.S. federal research tax credits, and excess tax benefits related to stock-based compensation.
During the second quarter of fiscal year 2021, we completed the acquisition of Mellanox. As a result of the acquisition, we recorded $256 million of net deferred tax liabilities primarily on the excess of book basis over the tax basis of the acquired intangible assets and undistributed earnings in certain foreign subsidiaries. We also recorded $153 million of long-term tax liabilities related to tax basis differences in Mellanox.
As of January 30, 2022, we intend to indefinitely reinvest approximately $1.05 billion and $232 million of cumulative undistributed earnings held by certain subsidiaries in Israel and the United Kingdom, respectively. We have not provided the amount of unrecognized deferred tax liabilities for temporary differences related to these investments as the determination of such amount is not practicable.
As of January 30, 2022 and January 31, 2021, we had a valuation allowance of $907 million and $728 million, respectively, related to state and certain other deferred tax assets that management determined not likely to be realized due, in part, to jurisdictional projections of future taxable income. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as income tax benefits during the period.
As of January 30, 2022, we had federal, state and foreign net operating loss carryforwards of $397 million, $345 million and $341 million, respectively. The federal and state carryforwards will begin to expire in fiscal year 2023. The foreign net operating loss carryforwards of $341 million may be carried forward indefinitely. As of January 30, 2022, we had federal research tax credit carryforwards of $102 million that will begin to expire in fiscal year 2042. We have state research tax credit carryforwards of $1.24 billion, of which $1.18 billion is attributable to the State of California and may be carried over indefinitely, and $55 million is attributable to various other states and will begin to expire in fiscal year 2023. Our tax attributes, net operating loss and tax credit carryforwards, remain subject to audit and may be adjusted for changes or modification in tax laws, other authoritative interpretations thereof, or other facts and circumstances. Utilization of federal, state, and foreign net operating losses and tax credit carryforwards may also be subject to limitations due to ownership changes and other limitations provided by the Internal Revenue Code and similar state and foreign tax provisions. If any such limitations apply, the federal, state, or foreign net operating loss and tax credit carryforwards, as applicable, may expire or be denied before utilization.
As of January 30, 2022, we had $1.01 billion of gross unrecognized tax benefits, of which $808 million would affect our effective tax rate if recognized. However, $181 million of the unrecognized tax benefits were related to state income tax positions taken, that, if recognized, would be in the form of a carryforward deferred tax asset that would likely attract a full valuation allowance. The $808 million of net unrecognized tax benefits as of January 30, 2022 consisted of $670 million recorded in non-current income taxes payable and $138 million reflected as a net reduction to the deferred tax assets.
A reconciliation of gross unrecognized tax benefits is as follows:
 January 30,
2022
January 31,
2021
January 26,
2020
 (In millions)
Balance at beginning of period$776 $583 $477 
Increases in tax positions for current year246 158 104 
Increases in tax positions for prior years (1)14 60 
Decreases in tax positions for prior years(4)(11)— 
Settlements(8)(5)— 
Lapse in statute of limitations(11)(9)(5)
Balance at end of period$1,013 $776 $583 
(1) The fiscal year 2021 balance represents prior year gross unrecognized tax benefits recorded as a result of the Mellanox acquisition.

We classify an unrecognized tax benefit as a current liability, or amount refundable, to the extent that we anticipate payment or receipt of cash for income taxes within one year. The amount is classified as a long-term liability, or reduction of long-term deferred tax assets or amount refundable, if we anticipate payment or receipt of cash for income taxes during a period beyond a year.
We include interest and penalties related to unrecognized tax benefits as a component of income tax expense. As of January 30, 2022, January 31, 2021, and January 26, 2020, we had accrued $59 million, $44 million, and $31 million, respectively, for the payment of interest and penalties related to unrecognized tax benefits, which is not included as a component of our unrecognized tax benefits. As of January 30, 2022, unrecognized tax benefits of $670 million and the related interest and penalties of $59 million are included in non-current income taxes payable.
While we believe that we have adequately provided for all tax positions, amounts asserted by tax authorities could be greater or less than our accrued position. Accordingly, our provisions on federal, state and foreign tax-related matters to be recorded in the future may change as revised estimates are made or the underlying matters are settled or otherwise resolved. As of January 30, 2022, we do not believe that our estimates, as otherwise provided for, on such tax positions will significantly increase or decrease within the next twelve months.
We are subject to taxation by taxing authorities both in the United States and other countries. As of January 30, 2022, the significant tax jurisdictions that may be subject to examination include China, Germany, Hong Kong, India, Israel, Taiwan, United Kingdom, and the United States for fiscal years 2005 through 2021. As of January 30, 2022, the significant tax jurisdictions for which we are currently under examination include Germany, India, Israel, and the United States for fiscal years 2005 through 2019.
v3.22.0.1
Shareholders’ Equity
12 Months Ended
Jan. 30, 2022
Equity [Abstract]  
Shareholders’ Equity Shareholders’ Equity
Capital Return Program
Beginning August 2004, our Board of Directors authorized us to repurchase our stock.
Through January 30, 2022, we have repurchased an aggregate of 1.04 billion shares under our share repurchase program for a total cost of $7.08 billion. As of January 30, 2022, we have a remaining authorization, subject to certain specifications, to repurchase shares of our common stock up to $7.24 billion through December 2022. From January 31, 2022 through March 17, 2022, we repurchased 7.7 million shares of our common stock for $1.75 billion.
During fiscal years 2022, 2021, and 2020, we paid $399 million, $395 million, and $390 million in cash dividends to our shareholders, respectively.
During the fourth quarter of fiscal year 2022, our Board of Directors approved the retirement of our existing 349 million treasury shares. These shares assumed the status of authorized and unissued shares upon retirement. The excess of repurchase price over par value was allocated between additional paid-in capital and retained earnings, resulting in a reduction in additional paid-in capital by $20 million and retained earnings by $12.0 billion. Any future repurchased shares will assume the status of authorized and unissued shares.
v3.22.0.1
Employee Retirement Plans
12 Months Ended
Jan. 30, 2022
Retirement Benefits [Abstract]  
Employee Retirement Plans Employee Retirement PlansWe provide tax-qualified defined contribution plans to eligible employees in the U.S. and certain other countries. Our contribution expense for fiscal years 2022, 2021, and 2020 was $168 million, $120 million, and $76 million, respectively.
v3.22.0.1
Segment Information
12 Months Ended
Jan. 30, 2022
Segment Reporting [Abstract]  
Segment Information Segment Information 
Our Chief Executive Officer, who is considered to be our chief operating decision maker, or CODM, reviews financial information presented on an operating segment basis for purposes of making decisions and assessing financial performance.
Our Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building 3D designs and virtual worlds.
Our Compute & Networking segment includes Data Center platforms and systems for AI, HPC, and accelerated computing; Mellanox networking and interconnect solutions; automotive AI Cockpit, autonomous driving development agreements, and autonomous vehicle solutions; CMP; Jetson for robotics and other embedded platforms; and NVIDIA AI Enterprise and other software.
Operating results by segment include costs or expenses that are directly attributable to each segment, and costs or expenses that are leveraged across our unified architecture and therefore allocated between our two segments.
The “All Other” category includes the expenses that our CODM does not assign to either Graphics or Compute & Networking for purposes of making operating decisions or assessing financial performance. The expenses include stock-based compensation expense, corporate infrastructure and support costs, acquisition-related costs, IP-related costs, and other non-recurring charges and benefits that our CODM deems to be enterprise in nature.
Our CODM does not review any information regarding total assets on a reportable segment basis. Depreciation and amortization expense directly attributable to each reportable segment is included in operating results for each segment. However, the CODM does not evaluate depreciation and amortization expense by operating segment and, therefore, it is not separately presented. There is no intersegment revenue. The accounting policies for segment reporting are the same as for our consolidated financial statements. The table below presents details of our reportable segments and the “All Other” category.
 GraphicsCompute & NetworkingAll OtherConsolidated
(In millions)
Year Ended January 30, 2022:
    
Revenue$15,868 $11,046 $— $26,914 
Operating income (loss)$8,492 $4,598 $(3,049)$10,041 
Year Ended January 31, 2021:
    
Revenue$9,834 $6,841 $— $16,675 
Operating income (loss)$4,612 $2,548 $(2,628)$4,532 
Year Ended January 26, 2020:
    
Revenue$7,639 $3,279 $— $10,918 
Operating income (loss)$3,267 $751 $(1,172)$2,846 
Year Ended
January 30,
2022
January 31,
2021
January 26,
2020
(In millions)
Reconciling items included in "All Other" category:
Stock-based compensation expense$(2,004)$(1,397)$(844)
Acquisition-related intangible asset amortization, inventory step-up charge, and other costs(636)(836)(31)
Unallocated cost of revenue and operating expenses(399)(357)(283)
IP-related costs(10)(38)(14)
Total$(3,049)$(2,628)$(1,172)
Revenue by geographic region is allocated to individual countries based on the location to which the products are initially billed even if our customers’ revenue is attributable to end customers that are located in a different location. The following table summarizes information pertaining to our revenue from customers based on the invoicing address by geographic regions: 
 Year Ended
 January 30,
2022
January 31,
2021
January 26,
2020
Revenue:(In millions)
Taiwan$8,544 $4,531 $3,025 
China (including Hong Kong)7,111 3,886 2,731 
United States4,349 3,214 886 
Other countries6,910 5,044 4,276 
Total revenue$26,914 $16,675 $10,918 
No customer represented 10% or more of total revenue for fiscal years 2022 and 2021. One customer represented 11% of our total revenue for fiscal year 2020 and was attributable primarily to the Graphics segment.
Two customers represented 22% of our accounts receivable balance as of January 30, 2022. One customer represented 16% of our accounts receivable balance as of January 31, 2021.
The following table summarizes information pertaining to our revenue by each of the specialized markets we serve:
 Year Ended
 January 30,
2022
January 31,
2021
January 26,
2020
Revenue:(In millions)
Gaming$12,462 $7,759 $5,518 
Data Center10,613 6,696 2,983 
Professional Visualization2,111 1,053 1,212 
Automotive566 536 700 
OEM & Other1,162 631 505 
Total revenue$26,914 $16,675 $10,918 
The following table presents summarized information for long-lived assets by country. Long-lived assets consist of property and equipment and exclude other assets, operating lease assets, goodwill, and intangible assets.
 January 30,
2022
January 31,
2021
Long-lived assets:(In millions)
United States$2,023 $1,643 
Taiwan379 183 
Israel185 147 
Other countries191 176 
Total long-lived assets$2,778 $2,149 
v3.22.0.1
SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS
12 Months Ended
Jan. 30, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS
SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS
DescriptionBalance at
Beginning of Period
Additions Deductions Balance at
End of Period
 (In millions)
Fiscal year 2022
      
Allowance for doubtful accounts$$— (1)$— (1)$
Sales return allowance$17 $19 (2)$(23)(4)$13 
Deferred tax valuation allowance$728 $179 (3)$— $907 
Fiscal year 2021
      
Allowance for doubtful accounts$$(1)$— (1)$
Sales return allowance$$30 (2)$(22)(4)$17 
Deferred tax valuation allowance$621 $107 (3)$— $728 
Fiscal year 2020
      
Allowance for doubtful accounts$$— (1)$— (1)$
Sales return allowance$$18 (2)$(17)(4)$
Deferred tax valuation allowance$562 $59 (3)$— $621 
(1)Additions represent either expense or acquired balances and deductions represent write-offs.
(2)Additions represent estimated product returns charged as a reduction to revenue or an acquired balance.
(3)Additional valuation allowance on deferred tax assets not likely to be realized. Refer to Note 14 of the Notes to the Consolidated Financial Statements in Part IV, Item 15 of this Annual Report on Form 10-K for additional information.
(4)Represents sales returns.
v3.22.0.1
Organization and Summary of Significant Accounting Policies (Policies)
12 Months Ended
Jan. 30, 2022
Accounting Policies [Abstract]  
Our Company
Our Company
Headquartered in Santa Clara, California, NVIDIA was incorporated in California in April 1993 and reincorporated in Delaware in April 1998.
All references to “NVIDIA,” “we,” “us,” “our” or the “Company” mean NVIDIA Corporation and its subsidiaries.
On July 19, 2021, we executed a four-for-one stock split of our common stock. All share, equity award, and per share amounts and related shareholders' equity balances presented herein have been retroactively adjusted to reflect the Stock Split.
Fiscal Year
Fiscal Year
We operate on a 52- or 53-week year, ending on the last Sunday in January. Fiscal years 2022 and 2020 were both 52-week years. Fiscal year 2021 was a 53-week year.
Reclassifications
Reclassifications
Certain prior fiscal year balances have been reclassified to conform to the current fiscal year presentation.
Principles of Consolidation
Principles of Consolidation
Our consolidated financial statements include the accounts of NVIDIA Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from our estimates. On an on-going basis, we evaluate our estimates, including those related to revenue recognition, cash equivalents and marketable securities, accounts receivable, inventories, income taxes, goodwill, stock-based compensation, litigation, investigation and settlement costs, restructuring and other charges, and other contingencies. The inputs into our judgments and estimates consider the economic implications of COVID-19. These estimates are based on historical facts and various other assumptions that we believe are reasonable.
Revenue Recognition
Revenue Recognition
We derive our revenue from product sales, including hardware and systems, license and development arrangements, software licensing, and cloud services. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract (where revenue is allocated on a relative standalone selling price basis by maximizing the use of observable inputs to determine the standalone selling price for each performance obligation); and (5) recognition of revenue when, or as, we satisfy a performance obligation.
Product Sales Revenue
Revenue from product sales is recognized upon transfer of control of products to customers in an amount that reflects the consideration we expect to receive in exchange for those products. Certain products are sold with support or an extended warranty for the incorporated system, hardware, and/or software. Support and extended warranty revenue are recognized ratably over the service period, or as services are performed. Revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers.
For products sold with a right of return, we record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized, based primarily on historical return rates. However, if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required to properly reflect our estimated exposure for product returns.
Our customer programs involve rebates, which are designed to serve as sales incentives to resellers of our products in various target markets, and marketing development funds, or MDFs, which represent monies paid to our partners that are earmarked for market segment development and are designed to support our partners’ activities while also promoting NVIDIA products. We account for customer programs as a reduction to revenue and accrue for potential rebates and MDFs based on the amount we expect to be claimed by customers.
License and Development Arrangements
Our license and development arrangements with customers typically require significant customization of our IP components. As a result, we recognize the revenue from the license and the revenue from the development services as a single performance obligation over the period in which the development services are performed. We measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project. If a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period.
Software Licensing
Our software licenses provide our customers with a right to use the software when it is made available to the customer. Customers may purchase either perpetual licenses or subscriptions to licenses, which differ mainly in the duration over which the customer benefits from the software. Software licenses are frequently sold along with the right to receive, on a when-and-if available basis, future unspecified software updates and upgrades. Revenue from software licenses is recognized up front when the software is made available to the customer. Software support revenue is recognized ratably over the service period, or as services are performed.
Cloud Services
Cloud services, which allow customers to use hosted software over the contract period without taking possession of the software, are provided on a subscription basis or a combination of subscription plus usage. Revenue related to subscription-based cloud services is recognized ratably over the contract period. Revenue related to cloud services based on usage is recognized as usage occurs.
Product Warranties
Product Warranties
We generally offer a limited warranty to end-users that ranges from one to three years for products in order to repair or replace products for any manufacturing defects or hardware component failures. Cost of revenue includes the estimated cost of product warranties that are calculated at the point of revenue recognition. Under limited circumstances, we may offer an extended limited warranty to customers for certain products. We also accrue for known warranty and indemnification issues if a loss is probable and can be reasonably estimated.
Stock-based Compensation
Stock-based Compensation
We use the closing trading price of our common stock on the date of grant, minus a dividend yield discount, as the fair value of awards of restricted stock units, or RSUs, and performance stock units that are based on our corporate financial performance targets, or PSUs. We use a Monte Carlo simulation on the date of grant to estimate the fair value of performance stock units that are based on market conditions, or market-based PSUs. The compensation expense for RSUs and market-based PSUs is recognized using a straight-line attribution method over the requisite employee service period while compensation expense for PSUs is recognized using an accelerated amortization model. We estimate the fair value of shares to be issued under our employee stock purchase plan, or ESPP, using the Black-Scholes model at the commencement of an offering period in March and September of each year. Stock-based compensation for our ESPP is expensed using an accelerated amortization model. Additionally, we estimate forfeitures at least annually based on historical experience and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates.
Litigation, Investigation and Settlement Costs
Litigation, Investigation and Settlement Costs
We currently, are, and will likely continue to be subject to claims, litigation, and other actions, including potential regulatory proceedings, involving patent and other intellectual property matters, taxes, labor and employment, competition and antitrust, commercial disputes, goods and services offered by us and by third parties, and other matters. There are many uncertainties associated with any litigation or investigation, and we cannot be certain that these actions or other third-party claims against us will be resolved without litigation, fines and/or substantial
settlement payments or judgements. If information becomes available that causes us to determine that a loss in any of our pending litigation, investigations or settlements is probable, and we can reasonably estimate the loss associated with such events, we will record the loss in accordance with U.S. GAAP. However, the actual liability in any such litigation or investigation may be materially different from our estimates, which could require us to record additional costs.
Foreign Currency Remeasurement
Foreign Currency Remeasurement
We use the United States dollar as our functional currency for all of our subsidiaries. Foreign currency monetary assets and liabilities are remeasured into United States dollars at end-of-period exchange rates. Non-monetary assets and liabilities such as property and equipment and equity are remeasured at historical exchange rates. Revenue and expenses are remeasured at exchange rates in effect during each period, except for those expenses related to non-monetary balance sheet amounts, which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in earnings in our Consolidated Statements of Income and to date have not been significant.
Income Taxes
Income Taxes
We recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized.
Our calculation of deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. Our estimates of deferred tax assets and liabilities may change based, in part, on added certainty or finality to an anticipated outcome, changes in accounting standards or tax laws in the United States, or foreign jurisdictions where we operate, or changes in other facts or circumstances. In addition, we recognize liabilities for potential United States and foreign income tax contingencies based on our estimate of whether, and the extent to which, additional taxes may be due. If we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly.
As of January 30, 2022, we had a valuation allowance of $907 million related to state and certain other deferred tax assets that management determined are not likely to be realized due to jurisdictional projections of future taxable income, tax attributes usage limitation by certain jurisdictions, and potential utilization limitations of tax attributes acquired as a result of stock ownership changes. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as an income tax benefit during the period.
We recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.
Net Income Per Share Net Income Per ShareBasic net income per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common and potentially dilutive shares outstanding during the period, using the treasury stock method. Under the treasury stock method, the effect of equity awards outstanding is not included in the computation of diluted net income per share for periods when their effect is anti-dilutive.
Cash and Cash Equivalents
Cash and Cash Equivalents and Marketable Securities
We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased. We currently classify our investments as current based on the nature of the investments and their availability for use in current operations.
We classify our cash equivalents and marketable securities related to debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of
tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the other income (expense), net, section of our Consolidated Statements of Income.
All of our available-for-sale debt investments are subject to a periodic impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or we intend to sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the other income (expense), net section of our Consolidated Statements of Income.
Marketable Securities
Cash and Cash Equivalents and Marketable Securities
We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased. We currently classify our investments as current based on the nature of the investments and their availability for use in current operations.
We classify our cash equivalents and marketable securities related to debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of
tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the other income (expense), net, section of our Consolidated Statements of Income.
All of our available-for-sale debt investments are subject to a periodic impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or we intend to sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the other income (expense), net section of our Consolidated Statements of Income.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The carrying value of cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their relatively short maturities as of January 30, 2022 and January 31, 2021. Marketable securities are comprised of available-for-sale securities that are reported at fair value with the related unrealized gains or losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. Fair value of the marketable securities is determined based on quoted market prices. Derivative instruments are recognized as either assets or liabilities and are measured at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. For derivative instruments designated as fair value hedges, the gains or losses are recognized in earnings in the periods of change together with the offsetting losses or gains on the hedged items attributed to the risk being hedged. For derivative instruments designated as cash-flow hedges, the effective portion of the gains or losses on the derivatives is initially reported as a component of other comprehensive income or loss and is subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments not designated for hedge accounting, changes in fair value are recognized in earnings.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, marketable securities, and accounts receivable. Our investment policy requires the purchase of highly-rated fixed income securities, the diversification of investment type and credit exposures, and includes certain limits on our portfolio duration. We perform ongoing credit evaluations of our customers’ financial condition and maintain an allowance for potential credit losses. This allowance consists of an amount identified for specific customers and an amount based on overall estimated exposure. Our overall estimated exposure excludes amounts covered by credit insurance and letters of credit.
Inventories
Inventories
Inventory cost is computed on an adjusted standard basis, which approximates actual cost on an average or first-in, first-out basis. Inventory costs consist primarily of the cost of semiconductors, including wafer fabrication, assembly, testing and packaging, manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, and shipping costs, as well as the cost of purchased memory products and other component parts. We charge cost of sales for inventory provisions to write-down our inventory to the lower of cost or net realizable value or for obsolete or excess inventory. Most of our inventory provisions relate to excess quantities of products, based on our inventory levels and future product purchase commitments compared to assumptions about future demand and market conditions. Once inventory has been written-off or written-down, it creates a new cost basis for the inventory that is not subsequently written-up. We record a liability for noncancelable purchase commitments with suppliers for quantities in excess of our future demand forecasts consistent with our valuation of obsolete or excess inventory.
Property and Equipment
Property and Equipment
Property and equipment are stated at cost. Depreciation of property and equipment is computed using the straight-line method based on the estimated useful lives of the assets, generally three to five years. Once an asset is identified for retirement or disposition, the related cost and accumulated depreciation or amortization are removed, and a gain or loss is recorded. The estimated useful lives of our buildings are up to thirty years. Depreciation expense includes the amortization of assets recorded under finance leases. Leasehold improvements and assets recorded under finance leases are amortized over the shorter of the expected lease term or the estimated useful life of the asset.
Leases
Leases
We determine if an arrangement is or contains a lease at inception. Operating leases with lease terms of more than 12 months are included in operating lease assets, accrued and other current liabilities, and long-term operating lease liabilities on our consolidated balance sheet. Operating lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term.
Operating lease assets and liabilities are recognized based on the present value of the remaining lease payments discounted using our incremental borrowing rate. Operating lease assets also include initial direct costs incurred and prepaid lease payments, minus any lease incentives. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.
We combine the lease and non-lease components in determining the operating lease assets and liabilities.
Goodwill
Goodwill
Goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier if indicators of potential impairment exist. For the purposes of completing our impairment test, we perform either a qualitative or a quantitative analysis on a reporting unit basis. 
Qualitative factors include industry and market considerations, overall financial performance, and other relevant events and factors affecting the reporting units.
Our quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit’s fair value. The income and market valuation approaches consider a number of factors that include, but are not limited to, prospective financial information, growth rates, residual values, discount rates and comparable multiples from publicly traded companies in our industry and require us to make certain assumptions and estimates regarding industry economic factors and the future profitability of our business.
Intangible Assets and Other Long-Lived Assets
Intangible Assets and Other Long-Lived Assets
Intangible assets primarily represent acquired intangible assets including developed technology, in-process research and development, or IPR&D, and customer relationships, as well as rights acquired under technology licenses, patents, and acquired IP. We currently amortize our intangible assets with finite lives over periods ranging from one to twenty years using a method that reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up or, if that pattern cannot be reliably determined, using a straight-line amortization method. We initially capitalize the fair value of IPR&D as an intangible asset with an indefinite life. When IPR&D projects are completed, we reclassify the IPR&D as an amortizable purchased intangible asset and amortize over the asset’s estimated useful life.
Long-lived assets, such as property and equipment and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of assets or asset groups to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset or asset group exceeds the estimated fair value of the asset or asset group. Fair value is determined based on the estimated discounted future cash flows expected to be generated by the asset or asset group. Assets and liabilities to be disposed of would be separately presented in the Consolidated Balance Sheet and the assets would be reported at the lower of the carrying amount or fair value less costs to sell, and would no longer be depreciated.
Business Combination
Business Combination
We allocate the fair value of the purchase price of an acquisition to the tangible assets acquired, liabilities assumed, and intangible assets acquired, including IPR&D, based on their estimated fair values. The excess of the fair value of the purchase price over the fair values of these net tangible and intangible assets acquired is recorded as goodwill. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but our estimates and assumptions are inherently uncertain and subject to refinement. The estimates and assumptions used in valuing intangible assets include, but are not limited to, the amount and timing of projected future cash flows, discount rate used
to determine the present value of these cash flows and asset lives. These estimates are inherently uncertain and, therefore, actual results may differ from the estimates made. As a result, during the measurement period of up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of the purchase price of an acquisition, whichever comes first, any subsequent adjustments are recorded to our Consolidated Statements of Income.
Acquisition-related expenses are recognized separately from the business combination and expensed as incurred.
Investment in Non-Affiliated Entities
Investment in Non-Affiliated Entities
Non-marketable equity investments in privately-held companies are recorded at fair value on a non-recurring basis only if an impairment or observable price adjustment occurs in the period with changes in fair value recorded through net income. These investments are valued using observable and unobservable inputs or data in an inactive market and the valuation requires our judgment due to the absence of market prices and inherent lack of liquidity. The estimated fair value is based on quantitative and qualitative factors including subsequent financing activities by the investee.
Marketable equity investments in publicly-held companies are recorded at fair value with the related unrealized and realized gains and losses recognized in other income (expense), net.
Adoption of New and Recently Issued Accounting Pronouncements
Adoption of New and Recently Issued Accounting Pronouncements
Recently Adopted Accounting Pronouncement
In October 2021, the Financial Accounting Standards Board issued a new accounting standard to require that an acquirer recognize and measure contract assets and liabilities acquired in a business combination in accordance with Accounting Standards Codification 606, Revenue from Contracts with Customers. We early adopted this accounting standard in the third quarter of fiscal year 2022 and the impact was immaterial.
v3.22.0.1
Business Combination (Tables)
12 Months Ended
Jan. 30, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The aggregate purchase consideration has been allocated as follows (in millions):
Purchase Price
Cash paid for outstanding Mellanox ordinary shares (1)$7,033 
Cash for Mellanox equity awards (2)16 
Total cash consideration7,049 
Fair value of Mellanox equity awards assumed by NVIDIA (3)85 
Total purchase consideration$7,134 
Allocation
Cash and cash equivalents$115 
Marketable securities699 
Accounts receivable, net216 
Inventories320 
Prepaid expenses and other assets179 
Property and equipment, net144 
Goodwill3,431 
Intangible assets2,970 
Accounts payable(136)
Accrued and other current liabilities(236)
Income tax liability(191)
Deferred income tax liability(258)
Other long-term liabilities(119)
$7,134 

(1)    Represents the cash consideration of $125.00 per share paid to Mellanox shareholders for approximately 56 million shares of outstanding Mellanox ordinary shares.
(2)    Represents the cash consideration for the settlement of approximately 249 thousand Mellanox stock options held by employees and non-employee directors of Mellanox.
(3)    Represents the fair value of Mellanox’s stock-based compensation awards attributable to pre-combination services.
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination
The estimated fair value and useful life of the acquired intangible assets at the time of the acquisition are as follows:
Fair ValueUseful Lives
(In millions)
Developed technology (1)$1,640 5 years
Customer relationships (2)440 3 years
Order backlog (3)190 Based on actual shipments
Trade names (4)70 5 years
Total identified finite-lived intangible assets2,340 
IPR&D (5)630 N/A
Total identified intangible assets$2,970 

(1)    The fair value of developed technology was identified using the Multi-Period Excess Earnings Method.
(2)    Customer relationships represent the fair value of the existing relationships using the With and Without Method.
(3)    Order backlog represents primarily the fair value of purchase arrangements with customers using the Multi-Period Excess Earnings Method. The intangible asset was fully amortized as of January 31, 2021.
(4)    Trade names primarily relate to Mellanox trade names and fair value was determined by applying the Relief-from-Royalty Method under the income approach.
(5)    The fair value of IPR&D was determined using the Multi-Period Excess Earnings Method.
Business Acquisition, Pro Forma Information
The following unaudited pro forma financial information summarizes the combined results of operations for NVIDIA and Mellanox as if the companies were combined as of the beginning of fiscal year 2020:
Pro Forma
 Year Ended
 January 31, 2021January 26, 2020
(In millions)
Revenue$17,104 $12,250 
Net income$4,757 $2,114 
v3.22.0.1
Leases (Tables)
12 Months Ended
Jan. 30, 2022
Leases [Abstract]  
Schedule of future minimum lease payments
Future minimum lease payments under our non-cancelable operating leases as of January 30, 2022, are as follows:
Operating Lease Obligations
 (In millions)
Fiscal Year: 
2023$176 
2024162 
2025136 
2026124 
2027114 
2028 and thereafter288 
Total1,000 
Less imputed interest115 
Present value of net future minimum lease payments885 
Less short-term operating lease liabilities144 
Long-term operating lease liabilities$741 
Schedule of other information related to leases
Other information related to leases was as follows:
Year Ended
January 30, 2022January 31, 2021January 26, 2020
 (In millions)
Supplemental cash flows information 
Operating cash flows used for operating leases$154 $141 $103 
Operating lease assets obtained in exchange for lease obligations (1)$266 $200 $238 
(1)    Fiscal year 2021 includes $80 million of operating lease assets addition due to Mellanox.
v3.22.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Jan. 30, 2022
Share-based Payment Arrangement [Abstract]  
Stock-based compensation expense, net of amounts capitalized as inventory
Our Consolidated Statements of Income include stock-based compensation expense, net of amounts allocated to inventory, as follows:
 Year Ended
January 30,
2022
January 31,
2021
January 26,
2020
 (In millions)
Cost of revenue$141 $88 $39 
Research and development1,298 860 540 
Sales, general and administrative565 449 265 
Total$2,004 $1,397 $844 
Summary of equity awards
The following is a summary of equity awards granted under our equity incentive plans:
Year Ended
January 30,
2022
January 31,
2021
January 26,
2020
(In millions, except per share data)
RSUs, PSUs and Market-based PSUs
Awards granted18 36 28 
Estimated total grant-date fair value$3,492 $2,764 $1,282 
Weighted average grant-date fair value per share$190.69 $76.81 $46.12 
ESPP
Shares purchased
Weighted average price per share$56.36 $34.80 $37.19 
Weighted average grant-date fair value per share$23.24 $16.91 $16.22 
Summary of ESPP valuation assumptions
The fair value of shares issued under our ESPP have been estimated with the following assumptions:
 Year Ended
 January 30,
2022
January 31,
2021
January 26,
2020
(Using the Black-Scholes model)
ESPP
Weighted average expected life (in years)
0.1-2.0
0.1-2.0
0.1-2.0
Risk-free interest rate
—%-0.5%
0.1%-1.6%
1.5%-2.6%
Volatility
20%-58%
26%-89%
30%-82%
Dividend yield
0.1%
0.1%-0.3%
0.3%-0.4%
Schedule of equity award transactions
The following is a summary of our equity award transactions under our equity incentive plans: 
RSUs, PSUs and Market-based PSUs Outstanding
 Number of SharesWeighted Average Grant-Date Fair Value
(In millions, except per share data)
Balances, January 31, 202159 $66.17 
Granted18 $190.69 
Vested restricted stock(29)$66.67 
Canceled and forfeited(2)$86.47 
Balances, January 30, 202246 $114.19 
Vested and expected to vest after January 30, 202246 $113.84 
v3.22.0.1
Net Income Per Share (Tables)
12 Months Ended
Jan. 30, 2022
Earnings Per Share [Abstract]  
Reconciliation of numerators and denominators of basic and diluted net income per share computations
The following is a reconciliation of the denominator of the basic and diluted net income per share computations for the periods presented:
 Year Ended
 January 30,
2022
January 31,
2021
January 26,
2020
 (In millions, except per share data)
Numerator:   
Net income$9,752 $4,332 $2,796 
Denominator:   
Basic weighted average shares2,496 2,467 2,439 
Dilutive impact of outstanding equity awards39 43 33 
Diluted weighted average shares2,535 2,510 2,472 
Net income per share:   
Basic (1)$3.91 $1.76 $1.15 
Diluted (2)$3.85 $1.73 $1.13 
Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive
21 12 44 
(1)    Calculated as net income divided by basic weighted average shares.
(2)    Calculated as net income divided by diluted weighted average shares.
v3.22.0.1
Amortizable Intangible Assets (Tables)
12 Months Ended
Jan. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of the components of our amortizable intangible assets
The components of our amortizable intangible assets are as follows:
 January 30, 2022January 31, 2021
 
Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
 (In millions)(In millions)
Acquisition-related intangible assets (1)$3,418 $(1,304)$2,114 $3,280 $(774)$2,506 
Patents and licensed technology717 (492)225 706 (475)231 
Total intangible assets$4,135 $(1,796)$2,339 $3,986 $(1,249)$2,737 
(1)    As of January 30, 2022, acquisition-related intangible assets include the fair value of a Mellanox in-process research and development project of $630 million, which has not yet commenced amortization.
v3.22.0.1
Cash Equivalents and Marketable Securities (Tables)
12 Months Ended
Jan. 30, 2022
Investments, Debt and Equity Securities [Abstract]  
Schedule of cash equivalents and marketable securities
The following is a summary of cash equivalents and marketable securities as of January 30, 2022 and January 31, 2021:
 January 30, 2022
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$9,977 $— $(3)$9,974 $1,102 $8,872 
Debt securities issued by the United States Treasury7,314 — (14)7,300 — 7,300 
Debt securities issued by United States government agencies1,612 — — 1,612 256 1,356 
Certificates of deposit1,561 — — 1,561 21 1,540 
Money market funds316 — — 316 316 — 
Foreign government bonds150 — — 150 — 150 
Total$20,930 $— $(17)$20,913 $1,695 $19,218 
 January 31, 2021
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$4,442 $$— $4,444 $234 $4,210 
Debt securities issued by United States government agencies2,975 — 2,976 28 2,948 
Debt securities issued by the United States Treasury2,846 — — 2,846 25 2,821 
Certificates of deposit705 — — 705 37 668 
Money market funds313 — — 313 313 — 
Foreign government bonds67 — — 67 — 67 
Total$11,348 $$— $11,351 $637 $10,714 
The amortized cost and estimated fair value of cash equivalents and marketable securities as of January 30, 2022 and January 31, 2021 are shown below by contractual maturity.
 January 30, 2022January 31, 2021
 Amortized
Cost
Estimated
Fair Value
Amortized
Cost
Estimated
Fair Value
 (In millions)
Less than one year$16,346 $16,343 $10,782 $10,783 
Due in 1 - 5 years4,584 4,570 566 568 
Total$20,930 $20,913 $11,348 $11,351 
Schedule of marketable securities in a continuous unrealized loss position
The following table provides the breakdown of unrealized losses as of January 30, 2022, aggregated by investment category and length of time that individual securities have been in a continuous loss position:
 Less than 12 Months12 Months or GreaterTotal
 Estimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized Loss
 (In millions)
Corporate debt securities$2,445 $(3)$19 $— $2,464 $(3)
Debt securities issued by the United States Treasury5,292 (14)— — 5,292 (14)
Total$7,737 $(17)$19 $— $7,756 $(17)
v3.22.0.1
Fair Value of Financial Assets and Liabilities (Tables)
12 Months Ended
Jan. 30, 2022
Fair Value Disclosures [Abstract]  
Schedule of fair value of financial assets and liabilities
Fair Value at
Pricing CategoryJanuary 30, 2022January 31, 2021
(In millions)
Assets
Cash equivalents and marketable securities:
Money market fundsLevel 1$316 $313 
Corporate debt securitiesLevel 2$9,974 $4,444 
Debt securities issued by the United States TreasuryLevel 2$7,300 $2,846 
Debt securities issued by United States government agenciesLevel 2$1,612 $2,976 
Certificates of depositLevel 2$1,561 $705 
Foreign government bondsLevel 2$150 $67 
Other assets (Investment in non-affiliated entities):
Publicly-held equity securities (1)Level 1$58 $— 
Privately-held equity securitiesLevel 3$208 $144 
Liabilities (2)
2.20% Notes Due 2021
Level 2$— $1,011 
0.309% Notes Due 2023
Level 2$1,236 $— 
0.584% Notes Due 2024
Level 2$1,224 $— 
3.20% Notes Due 2026
Level 2$1,055 $1,124 
1.55% Notes Due 2028
Level 2$1,200 $— 
2.85% Notes Due 2030
Level 2$1,542 $1,654 
2.00% Notes Due 2031
Level 2$1,200 $— 
3.50% Notes Due 2040
Level 2$1,066 $1,152 
3.50% Notes Due 2050
Level 2$2,147 $2,308 
3.70% Notes Due 2060
Level 2$551 $602 
(1)    Unrealized gains of $48 million from an investment in a publicly-traded equity security were recorded in other income (expense), net, in fiscal year 2022.
(2)    These liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs.
v3.22.0.1
Balance Sheet Components (Tables)
12 Months Ended
Jan. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Summary of inventory
 January 30,
2022
January 31,
2021
(In millions)
Inventories:
Raw materials$791 $632 
Work in-process692 457 
Finished goods1,122 737 
Total inventories$2,605 $1,826 
Summary of property and equipment
 January 30,
2022
January 31,
2021
Estimated
Useful Life
(In millions)(In years)
Property and Equipment:
Land$218 $218 (A)
Buildings, leasehold improvements, and furniture874 796 (B)
Equipment, compute hardware, and software2,852 1,985 
3-5
Construction in process737 558 (C)
Total property and equipment, gross4,681 3,557  
Accumulated depreciation and amortization(1,903)(1,408) 
Total property and equipment, net$2,778 $2,149  
(A)Land is a non-depreciable asset.
(B)The estimated useful lives of our buildings are up to thirty years. Leasehold improvements and finance leases are amortized based on the lesser of either the asset’s estimated useful life or the expected lease term.
(C)Construction in process represents assets that are not available for their intended use as of the balance sheet date.
Summary of other assets
 January 30,
2022
January 31,
2021
Other assets:(In millions)
Prepaid supply agreements$1,747 $— 
Advanced consideration for acquisition (1)1,357 1,357 
Prepaid royalties409 440 
Investment in non-affiliated entities266 144 
Other62 203 
Total other assets$3,841 $2,144 
(1)Refer to Note 2 - Business Combination for further details on the Arm acquisition.
Summary of accrued and other current liabilities
 January 30,
2022
January 31,
2021
(In millions)
Accrued and Other Current Liabilities:
Customer program accruals$1,000 $630 
Accrued payroll and related expenses409 297 
Deferred revenue (1)300 288 
Excess inventory purchase obligations196 52 
Other647 510 
Total accrued and other current liabilities$2,552 $1,777 
(1)Deferred revenue primarily includes customer advances and deferrals related to license and development arrangements, support for hardware and software, and cloud services.
Summary of other long-term liabilities
 January 30,
2022
January 31,
2021
(In millions)
Other Long-Term Liabilities:
Income tax payable (1)$980 $836 
Deferred income tax245 241 
Deferred revenue (2)202 163 
Other126 135 
Total other long-term liabilities$1,553 $1,375 
(1)As of January 30, 2022, income tax payable represents the long-term portion of the one-time transition tax payable of $251 million, long-term portion of the unrecognized tax benefits of $670 million, and related interest and penalties of $59 million.
(2)Deferred revenue primarily includes deferrals related to support for hardware and software.
Schedule of changes in deferred revenue
The following table shows the changes in deferred revenue during fiscal years 2022 and 2021.
 January 30,
2022
January 31,
2021
(In millions)
Balance at beginning of period$451 $201 
Deferred revenue added during the period821 536 
Addition due to business combinations75 
Revenue recognized during the period(778)(361)
Balance at end of period$502 $451 
v3.22.0.1
Derivative Financial Instruments (Tables)
12 Months Ended
Jan. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of notional value of our foreign currency forward contracts outstanding
The table below presents the notional value of our foreign currency forward contracts outstanding as of January 30, 2022 and January 31, 2021:
January 30,
2022
January 31,
2021
 (In millions)
Designated as cash flow hedges$1,023 $840 
Non-designated hedges$408 $441 
v3.22.0.1
Debt (Tables)
12 Months Ended
Jan. 30, 2022
Debt Disclosure [Abstract]  
Long-term Debt
The carrying value of the Notes, the calendar year of maturity, and the associated interest rates were as follows:
 Expected
Remaining Term (years)
Effective
Interest Rate
January 30,
2022
January 31,
2021
   (In millions)
2.20% Notes Due 2021
2.38%$— $1,000 
0.309% Notes Due 2023
1.40.41%1,250 — 
0.584% Notes Due 2024
2.40.66%1,250 — 
3.20% Notes Due 2026
4.63.31%1,000 1,000 
1.55% Notes Due 2028
6.41.64%1,250 — 
2.85% Notes Due 2030
8.22.93%1,500 1,500 
2.00% Notes Due 2031
9.42.09%1,250 — 
3.50% Notes Due 2040
18.23.54%1,000 1,000 
3.50% Notes Due 2050
28.23.54%2,000 2,000 
3.70% Notes Due 2060
38.23.73%500 500 
Unamortized debt discount and issuance costs  (54)(37)
Net carrying amount  10,946 6,963 
Less short-term portion— (999)
Total long-term portion$10,946 $5,964 
v3.22.0.1
Commitment and Contingencies (Tables)
12 Months Ended
Jan. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Purchase Obligation, Fiscal Year Maturity
Total future unconditional purchase commitments as of January 30, 2022, are as follows:
Commitments
 (In millions)
Fiscal Year: 
2023$9,302 
2024765 
2025201 
202628 
Total$10,296 
v3.22.0.1
Income Taxes (Tables)
12 Months Ended
Jan. 30, 2022
Income Tax Disclosure [Abstract]  
Schedule of income tax expense (benefit)
The income tax expense (benefit) applicable to income before income taxes consists of the following:
 Year Ended
 January 30,
2022
January 31,
2021
January 26,
2020
 (In millions)
Current income taxes:   
Federal$482 $197 $65 
State42 
Foreign71 161 87 
Total current595 359 156 
Deferred taxes:   
Federal(420)(246)
Foreign14 (36)16 
Total deferred(406)(282)18 
Income tax expense$189 $77 $174 
Schedule of income before income tax
Income before income tax consists of the following:
 Year Ended
 January 30,
2022
January 31,
2021
January 26,
2020
 (In millions)
Domestic (1)$8,446 $1,437 $620 
Foreign1,495 2,972 2,350 
Income before income tax$9,941 $4,409 $2,970 
(1)Fiscal year 2022 domestic income before income tax increased as compared to fiscal years 2021 and 2020 due to the Domestication in the second quarter of fiscal year 2022.
Schedule of effective income tax rate reconciliation The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21% to income before income taxes as follows:
 Year Ended
 January 30,
2022
January 31,
2021
January 26,
2020
 (In millions)
Tax expense computed at federal statutory rate$2,088 $926 $624 
Expense (benefit) resulting from:
State income taxes, net of federal tax effect42 10 12 
Foreign-derived intangible income(520)— — 
Foreign tax rate differential(497)(561)(301)
Stock-based compensation(337)(136)(60)
U.S. federal R&D tax credit(289)(173)(110)
IP domestication(244)— — 
Other(54)11 
Income tax expense$189 $77 $174 
Schedule of deferred tax assets and liabilities
The tax effect of temporary differences that gives rise to significant portions of the deferred tax assets and liabilities are presented below: 
 January 30,
2022
January 31,
2021
 (In millions)
Deferred tax assets: 
Research and other tax credit carryforwards$798 $650 
Property, equipment and intangible assets530 32 
GILTI deferred tax assets378 709 
Accruals and reserves, not currently deductible for tax purposes258 59 
Operating lease liabilities125 120 
Net operating loss carryforwards118 100 
Stock-based compensation86 36 
Other deferred tax assets22 — 
Gross deferred tax assets2,315 1,706 
Less valuation allowance(907)(728)
Total deferred tax assets1,408 978 
Deferred tax liabilities:  
Acquired intangibles(169)(191)
Unremitted earnings of foreign subsidiaries(150)(111)
Operating lease assets(113)(111)
Gross deferred tax liabilities(432)(413)
Net deferred tax asset (1)$976 $565 
(1) Net deferred tax asset includes long-term deferred tax assets of $1.22 billion and $806 million and long-term deferred tax liabilities of $245 million and $241 million for fiscal years 2022 and 2021, respectively. Long-term deferred tax liabilities are included in other long-term liabilities on our Consolidated Balance Sheets.
Summary of gross unrecognized tax benefits
A reconciliation of gross unrecognized tax benefits is as follows:
 January 30,
2022
January 31,
2021
January 26,
2020
 (In millions)
Balance at beginning of period$776 $583 $477 
Increases in tax positions for current year246 158 104 
Increases in tax positions for prior years (1)14 60 
Decreases in tax positions for prior years(4)(11)— 
Settlements(8)(5)— 
Lapse in statute of limitations(11)(9)(5)
Balance at end of period$1,013 $776 $583 
(1) The fiscal year 2021 balance represents prior year gross unrecognized tax benefits recorded as a result of the Mellanox acquisition.
v3.22.0.1
Segment Information (Tables)
12 Months Ended
Jan. 30, 2022
Segment Reporting [Abstract]  
Schedule of reportable segments
 GraphicsCompute & NetworkingAll OtherConsolidated
(In millions)
Year Ended January 30, 2022:
    
Revenue$15,868 $11,046 $— $26,914 
Operating income (loss)$8,492 $4,598 $(3,049)$10,041 
Year Ended January 31, 2021:
    
Revenue$9,834 $6,841 $— $16,675 
Operating income (loss)$4,612 $2,548 $(2,628)$4,532 
Year Ended January 26, 2020:
    
Revenue$7,639 $3,279 $— $10,918 
Operating income (loss)$3,267 $751 $(1,172)$2,846 
Year Ended
January 30,
2022
January 31,
2021
January 26,
2020
(In millions)
Reconciling items included in "All Other" category:
Stock-based compensation expense$(2,004)$(1,397)$(844)
Acquisition-related intangible asset amortization, inventory step-up charge, and other costs(636)(836)(31)
Unallocated cost of revenue and operating expenses(399)(357)(283)
IP-related costs(10)(38)(14)
Total$(3,049)$(2,628)$(1,172)
Schedule of revenue by geographic regions The following table summarizes information pertaining to our revenue from customers based on the invoicing address by geographic regions: 
 Year Ended
 January 30,
2022
January 31,
2021
January 26,
2020
Revenue:(In millions)
Taiwan$8,544 $4,531 $3,025 
China (including Hong Kong)7,111 3,886 2,731 
United States4,349 3,214 886 
Other countries6,910 5,044 4,276 
Total revenue$26,914 $16,675 $10,918 
Schedule of revenue by specialized markets
The following table summarizes information pertaining to our revenue by each of the specialized markets we serve:
 Year Ended
 January 30,
2022
January 31,
2021
January 26,
2020
Revenue:(In millions)
Gaming$12,462 $7,759 $5,518 
Data Center10,613 6,696 2,983 
Professional Visualization2,111 1,053 1,212 
Automotive566 536 700 
OEM & Other1,162 631 505 
Total revenue$26,914 $16,675 $10,918 
Summary of long-lived assets by geographic region
The following table presents summarized information for long-lived assets by country. Long-lived assets consist of property and equipment and exclude other assets, operating lease assets, goodwill, and intangible assets.
 January 30,
2022
January 31,
2021
Long-lived assets:(In millions)
United States$2,023 $1,643 
Taiwan379 183 
Israel185 147 
Other countries191 176 
Total long-lived assets$2,778 $2,149 
v3.22.0.1
Organization and Summary of Significant Accounting Policies (Details)
$ in Millions
12 Months Ended
Jul. 19, 2021
Jan. 30, 2022
USD ($)
Jan. 31, 2021
USD ($)
Property, Plant and Equipment [Line Items]      
Stock split ratio 4    
Deferred tax assets, valuation allowance   $ 907 $ 728
Buildings      
Property, Plant and Equipment [Line Items]      
Property, plant & equipment, useful life   30 years  
Minimum      
Property, Plant and Equipment [Line Items]      
Warranty liability, term   1 year  
Property, plant & equipment, useful life   3 years  
Intangible assets, useful life   1 year  
Maximum      
Property, Plant and Equipment [Line Items]      
Warranty liability, term   3 years  
Property, plant & equipment, useful life   5 years  
Intangible assets, useful life   20 years  
v3.22.0.1
Business Combination - Termination of the Arm Share Purchase Agreement, Additional Information (Details)
$ in Millions
3 Months Ended
May 01, 2022
USD ($)
Arm Limited | Forecast  
Business Acquisition [Line Items]  
Advanced consideration to be written off $ 1,360
v3.22.0.1
Business Combination - Acquisition of Mellanox Technologies, Additional Information (Details) - Mellanox Technologies, Ltd - USD ($)
$ in Millions
1 Months Ended 12 Months Ended
Apr. 30, 2020
Jan. 31, 2021
Jan. 26, 2020
Jan. 30, 2022
Apr. 27, 2020
Business Acquisition [Line Items]          
Merger agreement price $ 7,134        
Transaction costs   $ 28      
IPR&D       $ 630 $ 630
Fair value adjustment, inventory     $ 161    
Revenue | Revenue Stream Concentration Risk          
Business Acquisition [Line Items]          
Concentration risk (as percent)   10.00%      
v3.22.0.1
Business Combination - Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
1 Months Ended
Apr. 30, 2020
Jan. 30, 2022
Jan. 31, 2021
Apr. 27, 2020
Allocation        
Goodwill   $ 4,349 $ 4,193  
Mellanox Technologies, Ltd        
Purchase Price        
Total cash consideration $ 7,049      
Fair value of Mellanox equity awards assumed by NVIDIA 85      
Total purchase consideration 7,134      
Allocation        
Cash and cash equivalents 115      
Marketable securities 699      
Accounts receivable, net 216      
Inventories 320      
Prepaid expenses and other assets 179      
Property and equipment, net 144      
Goodwill 3,431      
Intangible assets 2,970     $ 2,970
Accounts payable (136)      
Accrued and other current liabilities (236)      
Income tax liability (191)      
Deferred income tax liability (258)      
Other long-term liabilities (119)      
Net assets acquired (liabilities assumed) $ 7,134      
Merger agreement price (in dollars per share) $ 125.00      
Mellanox Technologies, Ltd | Mellanox Technologies, Ltd        
Allocation        
Business combination, shares issued (in shares) 56,000      
Mellanox Technologies, Ltd | Equity awards        
Purchase Price        
Total cash consideration $ 16      
Mellanox Technologies, Ltd | Employee Stock Option | Mellanox Technologies, Ltd        
Allocation        
Acquiree stock options settled in cash (in shares) 249      
Mellanox Technologies, Ltd | Ordinary shares        
Purchase Price        
Total cash consideration $ 7,033      
v3.22.0.1
Business Combination - Intangible Assets Acquired (Details) - Mellanox Technologies, Ltd - USD ($)
$ in Millions
Apr. 27, 2020
Jan. 30, 2022
Apr. 30, 2020
Acquired Finite-Lived Intangible Assets [Line Items]      
Total identified finite-lived intangible assets $ 2,340    
IPR&D 630 $ 630  
Total identified intangible assets 2,970   $ 2,970
Developed Technology      
Acquired Finite-Lived Intangible Assets [Line Items]      
Total identified finite-lived intangible assets $ 1,640    
Weighted Average Useful Lives 5 years    
Customer relationships      
Acquired Finite-Lived Intangible Assets [Line Items]      
Total identified finite-lived intangible assets $ 440    
Weighted Average Useful Lives 3 years    
Order backlog      
Acquired Finite-Lived Intangible Assets [Line Items]      
Total identified finite-lived intangible assets $ 190    
Trade names      
Acquired Finite-Lived Intangible Assets [Line Items]      
Total identified finite-lived intangible assets $ 70    
Weighted Average Useful Lives 5 years    
v3.22.0.1
Business Combination - Pro Forma Information (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 31, 2021
Jan. 26, 2020
Business Combination and Asset Acquisition [Abstract]    
Revenue $ 17,104 $ 12,250
Net income $ 4,757 $ 2,114
v3.22.0.1
Leases - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Leases [Abstract]      
Operating lease expense $ 168 $ 145 $ 114
Weighted average remaining lease term - operating leases 7 years 1 month 6 days 7 years 7 months 6 days  
Weighted average discount rate - operating leases 2.51% 2.87%  
Lease not yet commenced, term of contract 7 years    
Lease not yet commenced, undiscounted amount $ 169    
v3.22.0.1
Leases - Schedule of future minimum payments (Details) - USD ($)
$ in Millions
Jan. 30, 2022
Jan. 31, 2021
Leases [Abstract]    
2023 $ 176  
2024 162  
2025 136  
2026 124  
2027 114  
2028 and thereafter 288  
Total 1,000  
Less imputed interest 115  
Present value of net future minimum lease payments $ 885  
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accrued and other current liabilities  
Less short-term operating lease liabilities $ 144  
Long-term operating lease liabilities $ 741 $ 634
v3.22.0.1
Leases - Schedule of other lease information (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Lessee, Lease, Description [Line Items]      
Operating cash flows used for operating leases $ 154 $ 141 $ 103
Operating lease assets obtained in exchange for lease obligations $ 266 200 $ 238
Mellanox Technologies, Ltd      
Lessee, Lease, Description [Line Items]      
Operating lease assets obtained in exchange for lease obligations   $ 80  
v3.22.0.1
Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense $ 2,004 $ 1,397 $ 844
Cost of revenue      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense 141 88 39
Research and development      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense 1,298 860 540
Sales, general and administrative      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense $ 565 $ 449 $ 265
v3.22.0.1
Stock-Based Compensation - Summary of Equity Awards (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 18    
Weighted average grant date fair value (in dollars per share) $ 190.69    
Shares purchased (in shares) 5 4 4
Summary of unearned SBC expense      
Unearned stock-based compensation expense $ 4,870    
RSUs, PSUs and Market-based PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 18 36 28
Estimated total grant-date fair value $ 3,492 $ 2,764 $ 1,282
Weighted average grant date fair value (in dollars per share) $ 190.69 $ 76.81 $ 46.12
Summary of unearned SBC expense      
Estimated weighted average amortization period 2 years 4 months 24 days    
Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average grant date fair value (in dollars per share) $ 23.24 16.91 16.22
Weighted average price (in dollars per share) $ 56.36 $ 34.80 $ 37.19
Summary of unearned SBC expense      
Estimated weighted average amortization period 10 months 24 days    
Fair Value Assumptions      
Risk free interest rate, minimum 0.00% 0.10% 1.50%
Risk free interest rate, maximum 0.50% 1.60% 2.60%
Volatility rate, minimum 20.00% 26.00% 30.00%
Volatility rate, maximum 58.00% 89.00% 82.00%
Dividend yield 0.10%    
Employee Stock Purchase Plan | Minimum      
Fair Value Assumptions      
Weighted average expected life (in years) 1 month 6 days 1 month 6 days 1 month 6 days
Dividend yield   0.10% 0.30%
Employee Stock Purchase Plan | Maximum      
Fair Value Assumptions      
Weighted average expected life (in years) 2 years 2 years 2 years
Dividend yield   0.30% 0.40%
v3.22.0.1
Stock-Based Compensation - Narrative (Details)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Jan. 30, 2022
USD ($)
period
$ / shares
shares
Jan. 31, 2021
USD ($)
shares
Jan. 26, 2020
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares may be issued under the Restated 2007 Plan (in shares) 50    
Outstanding stock options subject to exercise (in shares) 6    
Number of shares available for grant (in shares) 131 148  
Employee stock purchase plan, offering period duration 24 months    
Employee stock purchase plan, number of purchase periods in offering period | period 4    
Employee stock purchase plan, purchase period duration 6 months    
Exercisable options, total intrinsic value | $ $ 1,380    
Outstanding options, total intrinsic value | $ $ 1,380    
Exercisable options, average exercise price (in dollars per share) | $ / shares $ 3.55    
Outstanding options, average exercise price (in dollars per share) | $ / shares $ 3.55    
Exercisable options, average remaining term 1 year 1 month 6 days    
Outstanding options, average remaining term 1 year 1 month 6 days    
Total intrinsic value of options exercised during the period | $ $ 741 $ 521 $ 84
RSUs, PSUs and Market-based PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares available for grant (in shares) 131    
Total fair value of units as of respective vesting dates | $ $ 5,560 $ 2,670 $ 1,450
Restricted Stock Units (RSUs) | Tranche One      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 4 years    
Vesting rights (as percent) 25.00%    
Quarterly vesting schedule - RSUs and PSUs (as percent) 6.25%    
Restricted Stock Units (RSUs) | Tranche Two      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 3 years    
Vesting rights (as percent) 40.00%    
Quarterly vesting schedule - RSUs and PSUs (as percent) 7.50%    
Performance Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 4 years    
Vesting rights (as percent) 25.00%    
Quarterly vesting schedule - RSUs and PSUs (as percent) 6.25%    
Market-based PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 3 years    
Maximum issuable shares of Market-based PSUs, percentage (as percent) 100.00%    
Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Maximum employee subscription rate (as percent) 15.00%    
Purchase price of ESPP (as percent) 85.00%    
Shares reserved for future issuance (in shares) 233    
v3.22.0.1
Stock-Based Compensation - Equity Incentive Plans (Details)
shares in Millions
12 Months Ended
Jan. 30, 2022
$ / shares
shares
Number of Shares  
RSUs, PSUs and Market-based PSUs, outstanding, beginning balance (in shares) | shares 59
RSUs, PSUs and Market-based PSUs, granted (in shares) | shares 18
RSUs, PSUs and Market-based PSUs, vested (in shares) | shares (29)
RSUs, PSUs and Market-based PSUs, canceled and forfeited (in shares) | shares (2)
RSUs, PSUs and Market-based PSUs, outstanding, ending balance (in shares) | shares 46
Vested and expected to vest, RSUs, PSUs and Market-based PSUs (in shares) | shares 46
Weighted Average Grant-Date Fair Value  
PSUs and Market-based PSUs, weighted average grant date fair value, beginning balance (in USD per share) | $ / shares $ 66.17
PSUs and Market-based PSUs, weighted average grant date fair value, granted (in USD per share) | $ / shares 190.69
PSUs and Market-based PSUs, weighted average grant date fair value, vested (in USD per share) | $ / shares 66.67
PSUs and Market-based PSUs, weighted average grant date fair value, canceled and forfeited (in USD per share) | $ / shares 86.47
PSUs and Market-based PSUs, weighted average grant date fair value, ending balance (in USD per share) | $ / shares 114.19
Vested and expected to vest, RSUs, PSUs and Market-based PSUs, weighted average grant date fair value (in USD per share) | $ / shares $ 113.84
v3.22.0.1
Net Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Numerator:      
Net income $ 9,752 $ 4,332 $ 2,796
Denominator:      
Basic weighted average shares (in shares) 2,496 2,467 2,439
Equity awards (in shares) 39 43 33
Diluted weighted average shares (in shares) 2,535 2,510 2,472
Net income per share:      
Basic (in USD per share) $ 3.91 $ 1.76 $ 1.15
Diluted (in USD per share) $ 3.85 $ 1.73 $ 1.13
Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive (in shares) 21 12 44
v3.22.0.1
Goodwill (Details) - USD ($)
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Goodwill [Line Items]      
Goodwill $ 4,349,000,000 $ 4,193,000,000  
Goodwill acquired during period 156,000,000    
Goodwill impairment loss 0 0 $ 0
Graphics      
Goodwill [Line Items]      
Goodwill 361,000,000 347,000,000  
Changes in goodwill 13,000,000    
Compute & Networking      
Goodwill [Line Items]      
Goodwill 3,990,000,000 $ 3,850,000,000  
Changes in goodwill $ 143,000,000    
v3.22.0.1
Amortizable Intangible Assets (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Apr. 27, 2020
Finite-Lived Intangible Assets [Line Items]        
Gross Carrying Amount $ 4,135 $ 3,986    
Accumulated Amortization (1,796) (1,249)    
Net  Carrying Amount 2,339 2,737    
Amortization expense 563 612 $ 25  
Future amortization expense associated with intangible assets        
Fiscal 2023 585      
Fiscal 2024 461      
Fiscal 2025 405      
Fiscal 2026 121      
Fiscal 2027 16      
Fiscal 2028 and thereafter 121      
Mellanox Technologies, Ltd        
Finite-Lived Intangible Assets [Line Items]        
IPR&D 630     $ 630
Acquisition-related intangible assets        
Finite-Lived Intangible Assets [Line Items]        
Gross Carrying Amount 3,418 3,280    
Accumulated Amortization (1,304) (774)    
Net  Carrying Amount 2,114 2,506    
Patents and licensed technology        
Finite-Lived Intangible Assets [Line Items]        
Gross Carrying Amount 717 706    
Accumulated Amortization (492) (475)    
Net  Carrying Amount $ 225 $ 231    
v3.22.0.1
Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Millions
Jan. 30, 2022
Jan. 31, 2021
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost $ 20,930 $ 11,348
Unrealized Gain 0 3
Unrealized Loss (17) 0
Estimated Fair Value 20,913 11,351
Cash Equivalents 1,695 637
Marketable Securities 19,218 10,714
Corporate debt securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 9,977 4,442
Unrealized Gain 0 2
Unrealized Loss (3) 0
Estimated Fair Value 9,974 4,444
Cash Equivalents 1,102 234
Marketable Securities 8,872 4,210
Debt securities issued by the United States Treasury    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 7,314 2,846
Unrealized Gain 0 0
Unrealized Loss (14) 0
Estimated Fair Value 7,300 2,846
Cash Equivalents 0 25
Marketable Securities 7,300 2,821
Debt securities issued by United States government agencies    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 1,612 2,975
Unrealized Gain 0 1
Unrealized Loss 0 0
Estimated Fair Value 1,612 2,976
Cash Equivalents 256 28
Marketable Securities 1,356 2,948
Certificates of deposit    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 1,561 705
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value 1,561 705
Cash Equivalents 21 37
Marketable Securities 1,540 668
Money market funds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 316 313
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value 316 313
Cash Equivalents 316 313
Marketable Securities 0 0
Foreign government bonds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 150 67
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value 150 67
Cash Equivalents 0 0
Marketable Securities $ 150 $ 67
v3.22.0.1
Cash Equivalents and Marketable Securities - Unrealized Losses Aggregated by Investment Category (Details)
$ in Millions
Jan. 30, 2022
USD ($)
Estimated Fair Value  
Less than 12 Months $ 7,737
12 Months or Greater 19
Total 7,756
Gross Unrealized Loss  
Less than 12 Months (17)
12 Months or Greater 0
Total (17)
Corporate debt securities  
Estimated Fair Value  
Less than 12 Months 2,445
12 Months or Greater 19
Total 2,464
Gross Unrealized Loss  
Less than 12 Months (3)
12 Months or Greater 0
Total (3)
Debt securities issued by the United States Treasury  
Estimated Fair Value  
Less than 12 Months 5,292
12 Months or Greater 0
Total 5,292
Gross Unrealized Loss  
Less than 12 Months (14)
12 Months or Greater 0
Total $ (14)
v3.22.0.1
Cash Equivalents and Marketable Securities - Amortized Cost and Estimated Fair Value of Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Millions
Jan. 30, 2022
Jan. 31, 2021
Amortized Cost    
Less than one year $ 16,346 $ 10,782
Due in 1 - 5 years 4,584 566
Amortized Cost 20,930 11,348
Estimated Fair Value    
Less than one year 16,343 10,783
Due in 1 - 5 years 4,570 568
Estimated Fair Value $ 20,913 $ 11,351
v3.22.0.1
Fair Value of Financial Assets and Liabilities (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Aug. 16, 2021
Jan. 31, 2021
Assets      
Cash equivalents and marketable securities $ 20,913   $ 11,351
Investment in non-affiliated entities 266   144
Liabilities      
Unrealized gain recognized during the period $ 48    
2.20% Notes Due 2021      
Liabilities      
Interest rate (as percent) 2.20% 2.20%  
0.309% Notes Due 2023      
Liabilities      
Interest rate (as percent) 0.309%    
0.584% Notes Due 2024      
Liabilities      
Interest rate (as percent) 0.584%    
3.20% Notes Due 2026      
Liabilities      
Interest rate (as percent) 3.20%    
1.55% Notes Due 2028      
Liabilities      
Interest rate (as percent) 1.55%    
2.85% Notes Due 2030      
Liabilities      
Interest rate (as percent) 2.85%    
2.00% Notes Due 2031      
Liabilities      
Interest rate (as percent) 2.00%    
3.50% Notes Due 2040      
Liabilities      
Interest rate (as percent) 3.50%    
3.50% Notes Due 2050      
Liabilities      
Interest rate (as percent) 3.50%    
3.70% Notes Due 2060      
Liabilities      
Interest rate (as percent) 3.70%    
Level 1 | Money market funds      
Assets      
Cash equivalents and marketable securities $ 316   313
Level 1 | Publicly-held equity securities      
Assets      
Investment in non-affiliated entities 58   0
Level 2 | 2.20% Notes Due 2021      
Liabilities      
Long-term debt 0   1,011
Level 2 | 0.309% Notes Due 2023      
Liabilities      
Long-term debt 1,236   0
Level 2 | 0.584% Notes Due 2024      
Liabilities      
Long-term debt 1,224   0
Level 2 | 3.20% Notes Due 2026      
Liabilities      
Long-term debt 1,055   1,124
Level 2 | 1.55% Notes Due 2028      
Liabilities      
Long-term debt 1,200   0
Level 2 | 2.85% Notes Due 2030      
Liabilities      
Long-term debt 1,542   1,654
Level 2 | 2.00% Notes Due 2031      
Liabilities      
Long-term debt 1,200   0
Level 2 | 3.50% Notes Due 2040      
Liabilities      
Long-term debt 1,066   1,152
Level 2 | 3.50% Notes Due 2050      
Liabilities      
Long-term debt 2,147   2,308
Level 2 | 3.70% Notes Due 2060      
Liabilities      
Long-term debt 551   602
Level 2 | Corporate debt securities      
Assets      
Cash equivalents and marketable securities 9,974   4,444
Level 2 | Debt securities issued by the United States Treasury      
Assets      
Cash equivalents and marketable securities 7,300   2,846
Level 2 | Debt securities issued by United States government agencies      
Assets      
Cash equivalents and marketable securities 1,612   2,976
Level 2 | Certificates of deposit      
Assets      
Cash equivalents and marketable securities 1,561   705
Level 2 | Foreign government bonds      
Assets      
Cash equivalents and marketable securities 150   67
Level 3 | Privately-held equity securities      
Assets      
Investment in non-affiliated entities $ 208   $ 144
v3.22.0.1
Balance Sheet Components - Inventories (Details) - USD ($)
$ in Millions
Jan. 30, 2022
Jan. 31, 2021
Inventories:    
Raw materials $ 791 $ 632
Work in-process 692 457
Finished goods 1,122 737
Total inventories $ 2,605 $ 1,826
v3.22.0.1
Balance Sheet Components - Property and Equipment (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 4,681 $ 3,557
Accumulated depreciation and amortization (1,903) (1,408)
Total property and equipment, net $ 2,778 2,149
Minimum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 3 years  
Maximum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 5 years  
Land    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 218 218
Buildings, leasehold improvements, and furniture    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross 874 796
Equipment, compute hardware, and software    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 2,852 1,985
Equipment, compute hardware, and software | Minimum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 3 years  
Equipment, compute hardware, and software | Maximum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 5 years  
Construction in process    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 737 $ 558
Buildings    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 30 years  
v3.22.0.1
Balance Sheet Components - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Depreciation expense $ 611 $ 486 $ 355
Accumulated amortization of lease hold improvements and capital lease 265 223  
Capital expenditures incurred but not yet paid $ 258 $ 157 $ 212
v3.22.0.1
Balance Sheet Components - Other Assets (Details) - USD ($)
$ in Millions
Jan. 30, 2022
Jan. 31, 2021
Text Block [Abstract]    
Prepaid supply agreements $ 1,747 $ 0
Advanced consideration for acquisition 1,357 1,357
Prepaid royalties 409 440
Investment in non-affiliated entities 266 144
Other 62 203
Other assets $ 3,841 $ 2,144
v3.22.0.1
Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($)
$ in Millions
Jan. 30, 2022
Jan. 31, 2021
Accrued and Other Current Liabilities:    
Customer program accruals $ 1,000 $ 630
Accrued payroll and related expenses 409 297
Deferred revenue 300 288
Excess inventory purchase obligations 196 52
Other 647 510
Accrued and other current liabilities $ 2,552 $ 1,777
v3.22.0.1
Balance Sheet Components - Other Long-Term Liabilities (Details) - USD ($)
$ in Millions
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Other Long-Term Liabilities:      
Income tax payable $ 980 $ 836  
Deferred income tax 245 241  
Deferred revenue 202 163  
Other 126 135  
Total other long-term liabilities 1,553 1,375  
One time transition tax payable, noncurrent 251    
Unrecognized tax benefits 670    
Interest and penalties $ 59 $ 44 $ 31
v3.22.0.1
Balance Sheet Components - Deferred Revenue (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Movement in Deferred Revenue [Roll Forward]    
Balance at beginning of period $ 451 $ 201
Deferred revenue added during the period 821 536
Addition due to business combinations 8 75
Revenue recognized during the period (778) (361)
Balance at end of period $ 502 $ 451
v3.22.0.1
Balance Sheet Components - Revenue Remaining Performance Obligation (Details)
$ in Millions
Jan. 30, 2022
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation $ 624
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-31  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation (as percent) 49.00%
Expected performance period 12 months
v3.22.0.1
Derivative Financial Instruments (Details) - USD ($)
$ in Millions
Jan. 30, 2022
Jan. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Designated as cash flow hedges $ 1,023 $ 840
Non-designated hedges $ 408 $ 441
v3.22.0.1
Derivative Financial Instruments - Narrative (Details)
12 Months Ended
Jan. 30, 2022
Foreign currency forward contract  
Derivative [Line Items]  
Maximum maturity period 18 months
v3.22.0.1
Debt - Narrative (Details) - USD ($)
1 Months Ended 12 Months Ended
Aug. 16, 2021
Jun. 30, 2021
Mar. 31, 2020
Sep. 30, 2016
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Debt Instrument [Line Items]              
Proceeds from issuance of bet, net of issuance costs         $ 4,977,000,000 $ 4,968,000,000 $ 0
Repayment of debt         1,000,000,000 $ 0 $ 0
Outstanding commercial paper         0    
Commercial Paper              
Debt Instrument [Line Items]              
Current borrowing capacity         $ 575,000,000    
Notes Issued June 2021              
Debt Instrument [Line Items]              
Face amount of debt issued   $ 5,000,000,000          
Proceeds from issuance of bet, net of issuance costs   $ 4,980,000,000          
Notes Issued March 2020              
Debt Instrument [Line Items]              
Face amount of debt issued     $ 5,000,000,000        
Proceeds from issuance of bet, net of issuance costs     $ 4,970,000,000        
Notes Issued September 2016              
Debt Instrument [Line Items]              
Face amount of debt issued       $ 2,000,000,000      
Proceeds from issuance of bet, net of issuance costs       $ 1,980,000,000      
2.20% Notes Due 2021              
Debt Instrument [Line Items]              
Repayment of debt $ 1,000,000,000            
Interest rate (as percent) 2.20%       2.20%    
v3.22.0.1
Debt - Schedule of Debt (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Aug. 16, 2021
Jan. 31, 2021
Debt Instrument [Line Items]      
Unamortized debt discount and issuance costs $ (54)   $ (37)
Net carrying amount 10,946   6,963
Less short-term portion 0   (999)
Long-term debt $ 10,946   5,964
2.20% Notes Due 2021      
Debt Instrument [Line Items]      
Interest rate (as percent) 2.20% 2.20%  
Effective Interest Rate (as percent) 2.38%    
Gross carrying amount $ 0   1,000
0.309% Notes Due 2023      
Debt Instrument [Line Items]      
Interest rate (as percent) 0.309%    
Expected Remaining Term (years) 1 year 4 months 24 days    
Effective Interest Rate (as percent) 0.41%    
Gross carrying amount $ 1,250   0
0.584% Notes Due 2024      
Debt Instrument [Line Items]      
Interest rate (as percent) 0.584%    
Expected Remaining Term (years) 2 years 4 months 24 days    
Effective Interest Rate (as percent) 0.66%    
Gross carrying amount $ 1,250   0
3.20% Notes Due 2026      
Debt Instrument [Line Items]      
Interest rate (as percent) 3.20%    
Expected Remaining Term (years) 4 years 7 months 6 days    
Effective Interest Rate (as percent) 3.31%    
Gross carrying amount $ 1,000   1,000
1.55% Notes Due 2028      
Debt Instrument [Line Items]      
Interest rate (as percent) 1.55%    
Expected Remaining Term (years) 6 years 4 months 24 days    
Effective Interest Rate (as percent) 1.64%    
Gross carrying amount $ 1,250   0
2.85% Notes Due 2030      
Debt Instrument [Line Items]      
Interest rate (as percent) 2.85%    
Expected Remaining Term (years) 8 years 2 months 12 days    
Effective Interest Rate (as percent) 2.93%    
Gross carrying amount $ 1,500   1,500
2.00% Notes Due 2031      
Debt Instrument [Line Items]      
Interest rate (as percent) 2.00%    
Expected Remaining Term (years) 9 years 4 months 24 days    
Effective Interest Rate (as percent) 2.09%    
Gross carrying amount $ 1,250   0
3.50% Notes Due 2040      
Debt Instrument [Line Items]      
Interest rate (as percent) 3.50%    
Expected Remaining Term (years) 18 years 2 months 12 days    
Effective Interest Rate (as percent) 3.54%    
Gross carrying amount $ 1,000   1,000
3.50% Notes Due 2050      
Debt Instrument [Line Items]      
Interest rate (as percent) 3.50%    
Expected Remaining Term (years) 28 years 2 months 12 days    
Effective Interest Rate (as percent) 3.54%    
Gross carrying amount $ 2,000   2,000
3.70% Notes Due 2060      
Debt Instrument [Line Items]      
Interest rate (as percent) 3.70%    
Expected Remaining Term (years) 38 years 2 months 12 days    
Effective Interest Rate (as percent) 3.73%    
Gross carrying amount $ 500   $ 500
v3.22.0.1
Commitments and Contingencies - Narrative (Details) - USD ($)
$ in Millions
1 Months Ended
Mar. 17, 2022
Jan. 30, 2022
Jan. 31, 2021
Supply Commitment [Line Items]      
Supply agreements   $ 1,580  
Inventory purchase and long-term supply agreements   9,000  
Other purchase obligations   1,300  
Warranty accrual   $ 46 $ 22
Subsequent Event      
Supply Commitment [Line Items]      
Supply agreements $ 670    
Supply agreements, term 9 years    
v3.22.0.1
Commitment and Contingencies - Summary of Future Commitments Due by Year (Details)
$ in Millions
Jan. 30, 2022
USD ($)
Fiscal Year:  
2023 $ 9,302
2024 765
2025 201
2026 28
Total $ 10,296
v3.22.0.1
Income Taxes - Components of Income Tax Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Current income taxes:      
Federal $ 482 $ 197 $ 65
State 42 1 4
Foreign 71 161 87
Total current 595 359 156
Deferred taxes:      
Federal (420) (246) 2
Foreign 14 (36) 16
Total deferred (406) (282) 18
Income tax expense 189 77 174
Income before Income Taxes      
Domestic 8,446 1,437 620
Foreign 1,495 2,972 2,350
Income before income tax $ 9,941 $ 4,409 $ 2,970
v3.22.0.1
Income Taxes - Income Tax Reconciliation (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Income Tax Disclosure [Abstract]      
Tax expense computed at federal statutory rate $ 2,088 $ 926 $ 624
Expense (benefit) resulting from:      
State income taxes, net of federal tax effect 42 10 12
Foreign-derived intangible income (520) 0 0
Foreign tax rate differential (497) (561) (301)
Stock-based compensation (337) (136) (60)
U.S. federal R&D tax credit (289) (173) (110)
IP domestication (244) 0 0
Other (54) 11 9
Income tax expense $ 189 $ 77 $ 174
v3.22.0.1
Income Taxes - Deferred Taxes (Details) - USD ($)
$ in Millions
Jan. 30, 2022
Jan. 31, 2021
Deferred tax assets:    
Research and other tax credit carryforwards $ 798 $ 650
Property, equipment and intangible assets 530 32
GILTI deferred tax assets 378 709
Accruals and reserves, not currently deductible for tax purposes 258 59
Operating lease liabilities 125 120
Net operating loss carryforwards 118 100
Stock-based compensation 86 36
Other deferred tax assets 22 0
Gross deferred tax assets 2,315 1,706
Less valuation allowance (907) (728)
Total deferred tax assets 1,408 978
Deferred tax liabilities:    
Acquired intangibles (169) (191)
Unremitted earnings of foreign subsidiaries (150) (111)
Operating lease assets (113) (111)
Gross deferred tax liabilities (432) (413)
Net deferred tax asset 976 565
Deferred tax assets, noncurrent    
Deferred tax assets:    
Gross deferred tax assets 1,220 806
Other long-term liabilities    
Deferred tax liabilities:    
Gross deferred tax liabilities $ (245) $ (241)
v3.22.0.1
Income Taxes - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Aug. 01, 2021
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Jul. 26, 2020
Jan. 27, 2019
Income Tax Contingency [Line Items]            
Income tax expense   $ 189 $ 77 $ 174    
Effective tax rate (as percent)   1.90% 1.70% 5.90%    
Discrete income tax benefit, domestication $ 244          
Deferred tax assets, valuation allowance   $ 907 $ 728      
Gross unrecognized tax benefits   1,013 776 $ 583   $ 477
Unrecognized tax benefits that would affect effective tax rate   808        
Unrecognized tax benefit related to state tax positions   181        
Reduction of deferred tax asset included in unrecognized tax benefit   138        
Interest and penalties   59 $ 44 $ 31    
Other long-term liabilities            
Income Tax Contingency [Line Items]            
Unrecognized tax benefits that would affect effective tax rate   670        
Interest and penalties   59        
Mellanox Technologies, Ltd            
Income Tax Contingency [Line Items]            
Deferred tax liabilities, intangibles and undistributed earnings from foreign subsidiaries         $ 256  
Deferred liabilities, inside basis difference in acquired business         $ 153  
Mellanox Technologies, Ltd | Israel            
Income Tax Contingency [Line Items]            
Undistributed earnings of foreign subsidiaries   1,050        
Mellanox Technologies, Ltd | United Kingdom            
Income Tax Contingency [Line Items]            
Undistributed earnings of foreign subsidiaries   232        
Federal            
Income Tax Contingency [Line Items]            
Net operating loss carryforwards   397        
Research tax credit carryforwards   102        
Foreign Country            
Income Tax Contingency [Line Items]            
Net operating loss carryforwards   341        
State and Local Jurisdiction            
Income Tax Contingency [Line Items]            
Net operating loss carryforwards   345        
Research tax credit carryforwards   1,240        
California            
Income Tax Contingency [Line Items]            
Research tax credit carryforwards   1,180        
Other states            
Income Tax Contingency [Line Items]            
Research tax credit carryforwards   $ 55        
v3.22.0.1
Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Balance at beginning of period $ 776 $ 583 $ 477
Increases in tax positions for current year 246 158 104
Increases in tax positions for prior years 14 60 7
Decreases in tax positions for prior years (4) (11) 0
Settlements (8) (5) 0
Lapse in statute of limitations (11) (9) (5)
Balance at end of period $ 1,013 $ 776 $ 583
v3.22.0.1
Shareholders' Equity (Details) - USD ($)
shares in Millions, $ in Millions
2 Months Ended 3 Months Ended 12 Months Ended
Mar. 17, 2022
Jan. 30, 2022
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Equity, Class of Treasury Stock [Line Items]          
Aggregate number of shares repurchased under stock repurchase program (in shares)     1,040.0    
Aggregated cost of shares repurchased   $ 7,080 $ 7,080    
Remaining authorized shares repurchase amount   $ 7,240 7,240    
Dividends paid     399 $ 395 $ 390
Retirement of treasury stock (in shares)   349.0      
Retirement of treasury stock     0    
Subsequent Event          
Equity, Class of Treasury Stock [Line Items]          
Number of share repurchased (in shares) 7.7        
Values of share repurchase $ 1,750        
Additional Paid-in Capital          
Equity, Class of Treasury Stock [Line Items]          
Retirement of treasury stock   $ 20 20    
Retained Earnings          
Equity, Class of Treasury Stock [Line Items]          
Retirement of treasury stock   $ 12,000 $ 12,026    
v3.22.0.1
Employee Retirement Plans (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Retirement Benefits [Abstract]      
Defined contribution plan costs $ 168 $ 120 $ 76
v3.22.0.1
Segment Information - Narrative (Details)
12 Months Ended
Jan. 30, 2022
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
v3.22.0.1
Segment Information - Reportable Segments (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Segment Reporting Information [Line Items]      
Revenue $ 26,914 $ 16,675 $ 10,918
Operating income (loss) 10,041 4,532 2,846
All Other      
Segment Reporting Information [Line Items]      
Revenue 0 0 0
Operating income (loss) (3,049) (2,628) (1,172)
Graphics | Operating segments      
Segment Reporting Information [Line Items]      
Revenue 15,868 9,834 7,639
Operating income (loss) 8,492 4,612 3,267
Compute & Networking | Operating segments      
Segment Reporting Information [Line Items]      
Revenue 11,046 6,841 3,279
Operating income (loss) $ 4,598 $ 2,548 $ 751
v3.22.0.1
Segment Information - Reconciling Items (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Segment Reporting Information [Line Items]      
Stock-based compensation expense $ (2,004) $ (1,397) $ (844)
Operating income (loss) 10,041 4,532 2,846
All Other      
Segment Reporting Information [Line Items]      
Stock-based compensation expense (2,004) (1,397) (844)
Acquisition-related intangible asset amortization, inventory step-up charge, and other costs (636) (836) (31)
Unallocated cost of revenue and operating expenses (399) (357) (283)
IP-related costs (10) (38) (14)
Operating income (loss) $ (3,049) $ (2,628) $ (1,172)
v3.22.0.1
Segment Information - Revenue and Long-lived Assets by Region (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Revenues and Long-Lived Assets      
Revenue $ 26,914 $ 16,675 $ 10,918
Long-lived assets 2,778 2,149  
Taiwan      
Revenues and Long-Lived Assets      
Revenue 8,544 4,531 3,025
Long-lived assets 379 183  
China (including Hong Kong)      
Revenues and Long-Lived Assets      
Revenue 7,111 3,886 2,731
United States      
Revenues and Long-Lived Assets      
Revenue 4,349 3,214 886
Long-lived assets 2,023 1,643  
Israel      
Revenues and Long-Lived Assets      
Long-lived assets 185 147  
Other countries      
Revenues and Long-Lived Assets      
Revenue 6,910 5,044 $ 4,276
Long-lived assets $ 191 $ 176  
v3.22.0.1
Segment Information - Revenue and Accounts Receivable by Major Customer (Details) - Customer Concentration Risk
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Significant Customer | Revenue      
Revenue, Major Customer [Line Items]      
Concentration risk (as percent)     11.00%
Significant Customer | Accounts Receivable      
Revenue, Major Customer [Line Items]      
Concentration risk (as percent)   16.00%  
Two Customers | Accounts Receivable      
Revenue, Major Customer [Line Items]      
Concentration risk (as percent) 22.00%    
v3.22.0.1
Segment Information - Schedule of Revenue by Market (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Revenue from External Customer [Line Items]      
Revenue $ 26,914 $ 16,675 $ 10,918
Gaming      
Revenue from External Customer [Line Items]      
Revenue 12,462 7,759 5,518
Data Center      
Revenue from External Customer [Line Items]      
Revenue 10,613 6,696 2,983
Professional Visualization      
Revenue from External Customer [Line Items]      
Revenue 2,111 1,053 1,212
Automotive      
Revenue from External Customer [Line Items]      
Revenue 566 536 700
OEM & Other      
Revenue from External Customer [Line Items]      
Revenue $ 1,162 $ 631 $ 505
v3.22.0.1
SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Allowance for doubtful accounts      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period $ 4 $ 2 $ 2
Additions 0 2 0
Deductions 0 0 0
Balance at End of Period 4 4 2
Sales return allowance      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 17 9 8
Additions 19 30 18
Deductions (23) (22) (17)
Balance at End of Period 13 17 9
Deferred tax valuation allowance      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 728 621 562
Additions 179 107 59
Deductions 0 0 0
Balance at End of Period $ 907 $ 728 $ 621